var data={"specialtyName":"Authors and Editors in Dermatology","contributorTypes":[{"name":"Editors-in-Chief","contributors":[{"name":"Jeffrey Callen, MD, FACP, FAAD","credentials":["Editor-in-Chief — Dermatology\n","Section Editor — Skin and Systemic Disease\n","Professor of Medicine\n","University of Louisville School of Medicine"],"disclosure":"Speaker's Bureau: Biogen [Cutaneous drug reactions in patients with multiple sclerosis]. Consultant/Advisory Boards: Eli Lilly and Company [Pemphigus and hidradenitis (Potential future drugs)]; Amgen [Lupus erythematosus (Potential future drugs)]; Biogen [Cutaneous reaction presentations for neurologists]. Equity Ownership/Stock Ownership: Celgene; Pfizer; 3M; Johnson and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and Gamble; CVS; Walgreens [Various dermatologic conditions (Thalidomide, apremilast, etanercept, adalimumab, tofacitinib)]. Equity Ownership/Stock Ownership (Spouse): Allergen; Celgene; Pfizer; 3M; Johnson and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and Gamble; Amgen; CVS; Walgreens [Various dermatologic conditions (Thalidomide, apremilast, etanercept, adalimumab, tofacitinib)]."}]},{"name":"Deputy Editors","contributors":[{"name":"Rosamaria Corona, MD, DSc","credentials":["Deputy Editor — Dermatology"],"disclosure":""},{"name":"Abena O Ofori, MD","credentials":["Deputy Editor — Dermatology\n","Assistant Professor of Medicine, Dermatology Division\n","Medical College of Georgia"],"disclosure":""}]},{"name":"Section Editors","contributors":[{"name":"Jeffrey Callen, MD, FACP, FAAD","credentials":["Editor-in-Chief — Dermatology\n","Section Editor — Skin and Systemic Disease\n","Professor of Medicine\n","University of Louisville School of Medicine"],"disclosure":"Speaker's Bureau: Biogen [Cutaneous drug reactions in patients with multiple sclerosis]. Consultant/Advisory Boards: Eli Lilly and Company [Pemphigus and hidradenitis (Potential future drugs)]; Amgen [Lupus erythematosus (Potential future drugs)]; Biogen [Cutaneous reaction presentations for neurologists]. Equity Ownership/Stock Ownership: Celgene; Pfizer; 3M; Johnson and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and Gamble; CVS; Walgreens [Various dermatologic conditions (Thalidomide, apremilast, etanercept, adalimumab, tofacitinib)]. Equity Ownership/Stock Ownership (Spouse): Allergen; Celgene; Pfizer; 3M; Johnson and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and Gamble; Amgen; CVS; Walgreens [Various dermatologic conditions (Thalidomide, apremilast, etanercept, adalimumab, tofacitinib)]."},{"name":"Kristina Callis Duffin, MD","credentials":["Section Editor — Psoriasis\n","Associate Professor, Department of Dermatology\n","University of Utah"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Psoriasis (Etanercept and brodalumab)]; AbbVie Inc. [Psoriasis (Adalimumab)]; Celgene Corporation [Psoriasis (Apremilast)]; Eli Lilly and Company [Psoriasis (Ixekizumab and baricitinib)]; Novartis [Psoriasis (Secukinumab)]; Bristol-Myers Squibb Company [Psoriasis (Abatacept)]; Pfizer Inc. [Psoriasis (Tofacitinib)]; Janssen Pharmaceutica [Psoriasis (Ustekinumab, guselkumab, golimumab, and infliximab)]; Stiefel Laboratories [Psoriasis (Calcipotriene)]. Consultant/Advisory Boards: Amgen [Psoriasis (Etanercept and brodalumab)]; AbbVie Inc. [Psoriasis (Adalimumab)]; Celgene Corporation [Psoriasis (Apremilast)]; Eli Lilly and Company [Psoriasis (Ixekizumab and baricitinib)]; Novartis [Psoriasis (Secukinumab)]; Bristol-Myers Squibb Company [Psoriasis (Abatacept)]; Pfizer Inc. [Psoriasis (Tofacitinib)]; Janssen Pharmaceutica [Psoriasis (Ustekinumab, guselkumab, golimumab, and infliximab)]; Stiefel Laboratories [Psoriasis (Calcipotriene)]."},{"name":"Mark V Dahl, MD","credentials":["Section Editor — Acne and Rosacea\n","Professor Emeritus\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Robert P Dellavalle, MD, PhD, MSPH","credentials":["Section Editor — General Dermatology\n","Professor of Dermatology and Public Health\n","University of Colorado School of Medicine\n","Colorado School of Public Health\n","Chief, Dermatology Service\n","US Department of Veterans Affairs\n","Eastern Colorado Health Care System"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer Pharmaceuticals [Independent research grant to the University of Colorado (Development of patient decision aids)]. Other Financial Interest: Editorial stipends from the Journal of Investigative Dermatology and the Journal of the American Academy of Dermatology."},{"name":"Jeffrey S Dover, MD, FRCPC","credentials":["Section Editor — Cosmetic Dermatology\n","Associate Clinical Professor of Dermatology\n","Yale University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan; Evolus; Valeant Pharmaceuticals [Neuromodulators, fillers]; Cutera; Cynosure; Lumenis; Syneron; Valeant Pharmaceuticals [Lasers, lights]; Merz [Toxin, filler]; Shaser Bioscience [Intense pulse light hair removal (Hair removal device)]; Zeltiq Aesthetics [Body contouring (Fat loss system)]; Revance [Neuromodulator]; Sienna [Lasers]. Consultant/Advisory Boards: Maison de Beaute; Web MD; Sky Biodevices; Syneron; Shaser Bioscience; Cutera; Cynosure; Lumenis; Valeant Pharmaceuticals [Lasers, lights]; Kythera Biopharmaceuticals [Fat saponification]; Myoscience [Neuromuscular]; Topokine Therapeutics [Fat modulation (Biologics)]; Zeltiq Aesthetics [Body contouring (Fat loss system)]; Valeant Pharmaceuticals [Fillers, toxin]; Sienna [Lasers]. Equity Ownership/Stock Options: CVS/Skin Effects [Skin care]; Shaser Bioscience [Intense pulse light hair removal (Hair removal device)]; Sky Biodevices [Skin cancer screening]. Other Financial Interest: Cynosure; Lumenis; Syneron [Use of equipment (Lasers, lights)]."},{"name":"Craig A Elmets, MD","credentials":["Section Editor — Photodermatology\n","Professor and Chair of Dermatology\n","University of Alabama at Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: Solgenix [CTCL (SGX301)]; Kyowa Hakko USA [CTCL (Mogamulizumab)]; CA Assn of Wine Growers [Photoprotection (Grapes)]; Ferndale Labs [Photoprotection (Polypodium leukotomos)]; Elorac [CTCL (Topical Naloxone]); Idera [Dermatomyositis (IMO-8400)]. Consultant/Advisory Boards: Ferndale Labs [Photoprotection (Polypodium leukotomos)]; Astellas Pharma US [Data Safety Monitoring Board - Atopic Dermatitis (Tacrolimus)]. Equity Ownership/Stock Options: Aevi Genomic Medicine (Gene therapy); Vaxin (Topical vaccines)."},{"name":"Joseph Fowler, MD","credentials":["Section Editor — Dermatitis\n","Clinical Professor of Dermatology\n","University of Louisville School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Galderma, Merck; Pfizer; Novartis; Lilly;  Regeneron [Acne, Eczema, psoriasis (Trifarotene, Crisaborole, MK3223, tofacitinib, secukinumab, ixekizumab,  dupilumab)]. Speaker's Bureau: SmartPractice [Eczema (Crisaborole, epicutaneous patch test)]. Consultant/Advisory Boards: Intraderm [Eczema (Hypochlorous acid)]."},{"name":"Jennifer L Hand, MD","credentials":["Section Editor — Genodermatoses\n","Associate Professor of Dermatology, Medical Genetics, and Pediatrics\n","Mayo Clinic, Rochester, MN"],"disclosure":""},{"name":"Maria Hordinsky, MD","credentials":["Section Editor — Hair and Scalp Disease\n","Chair and Professor - Department of Dermatology\n","University of Minnesota Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Incyte Corporation [Alopecia areata (Topical Janus kinase inhibitor)]; Allergan [Male pattern baldness (Setipiprant tablets)]; Pfizer [Alopecia areata (Oral Janus kinase inhibitor)]. Consultant/Advisory Boards: Concert Pharmaceuticals [Alopecia areata (Oral Janus kinase inhibitor)]; BiologicsMD [Alopecia, androgenetic alopecia (Hair cycle stimulator, subcutaneous injection)]; Bionz [Alopecia areata]. Other financial interest: Pantene Institute/Proctor & Gamble (Hair care products)."},{"name":"Moise L Levy, MD","credentials":["Section Editor — Pediatric Dermatology\n","Professor of Pediatrics and Medicine (Dermatology)\n","Dell Medical School, University of Texas, Austin\n","Clinical Professor of Dermatology and Pediatrics\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Anacor Pharmaceuticals [Atopic dermatitis (Investigational drug)]; Scioderm [Epidermolysis bullosa (Topical treatment investigation)]. Speaker's Bureau: Anacor Pharmaceuticals [Atopic dermatitis (Investigational drug)]. Consultant/Advisory Boards: Castle Creek Pharmaceuticals [Epidermolysis bullosa (New drug in development)]. Patent Holder: Incontinentia pigmenti (NEMO gene mutations)."},{"name":"Stanley J Miller, MD","credentials":["Section Editor — Dermatologic Surgery\n","Associate Professor of Dermatology and Otolaryngology/Head and Neck Surgery, Part-Time\n","Johns Hopkins Hospital"],"disclosure":""},{"name":"Maja Mockenhaupt, MD, PhD","credentials":["Section Editor — Drug Eruptions\n","Professor of Dermatology\n","Medical Center - University of Freiburg, Germany"],"disclosure":"Grant/Research/Clinical Trial Support: Tibotec; Janssen; Gruenenthal; GlaxoSmithKline; Sanofi-Aventis; AB-Science; Boehringer Ingelheim; UCB-Biopharma [Severe cutaneous adverse reactions (Epidemiologic studies of severe cutaneous adverse reactions)]. Consultant/Advisory Boards: Merck; Pfizer [Severe cutaneous adverse reactions]."},{"name":"June K Robinson, MD","credentials":["Section Editor — Nonmelanoma Skin Cancer\n","Professor of Clinical Dermatology\n","Northwestern University Feinberg School of Medicine"],"disclosure":""},{"name":"Ted Rosen, MD","credentials":["Section Editor — Infections and Infestations\n","Professor, Department of Dermatology\n","Baylor College of Medicine"],"disclosure":"Consultant/Advisory Boards: Cipher [Herpes labialis (Acyclovir buccal tablet)]; Medimetriks [Impetigo (Ozenoxacin topical)]."},{"name":"Jean-Claude Roujeau, MD","credentials":["Section Editor — Drug Eruptions\n","Emeritus Professor of Dermatology\n","Université Paris-Est Créteil (UPEC), Créteil, France"],"disclosure":"Consultant/Advisory Boards: AB Science [Mastocytosis (Masitinib)]; SK Biopharmaceuticals [Epilepsy (YKP3089, a new AED in development)]."},{"name":"Robert S Stern, MD","credentials":["Section Editor — Nonmelanoma Skin Cancer\n","Professor of Dermatology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Bristol-Myers Squibb [Advance skin cancer (Checkpoint inhibitors)]; Plexxikon [Advance skin cancer (Various drugs)]; Hydra [Advance skin cancer (Various drugs)]. Other Financial Interest: Mylan [Skin reactions (Expert in product liability case concerning phenytoin skin reaction)]; United State Department of Justice [Malpractice defense]."},{"name":"Erik Stratman, MD","credentials":["Section Editor — Dermatologic Diagnosis\n","Clinical Professor of Dermatology\n","University of Wisconsin Madison"],"disclosure":""},{"name":"Hensin Tsao, MD, PhD","credentials":["Section Editor — Melanocytic Lesions and Disorders of Pigmentation\n","Professor of Dermatology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Epiphany Dermatology [Med advisory board]."},{"name":"John A Zic, MD","credentials":["Section Editor — Cutaneous Lymphoma\n","Associate Professor of Medicine/Dermatology\n","Vanderbilt University School of Medicine"],"disclosure":"Other Financial Interest: Response Review Committee Member Icon; Imaging Millennium [Treatment of advanced stage (IIB to IV) mycosis fungoides (Brentuximab vedotin)]."},{"name":"John J Zone, MD","credentials":["Section Editor — Bullous Disease\n","Professor and Chairman, Department of Dermatology\n","University of Utah"],"disclosure":""}]},{"name":"Editorial Assistants","contributors":[{"name":"Mark Gilbert, MA","credentials":["Editorial Assistant – UpToDate"],"disclosure":""}]},{"name":"Authors","contributors":[{"name":"Sumaira Z Aasi, MD","credentials":["Professor\n","Department of Dermatology\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Ossama Abbas, MD","credentials":["Assistant Professor, Department of Dermatology\n","American University of Beirut Medical Center"],"disclosure":""},{"name":"David R Adams, MD, PharmD","credentials":["Associate Professor of Dermatology\n","Penn State Hershey Med Center"],"disclosure":""},{"name":"Denise Adams, MD","credentials":["Co-Director of the Vascular Anomalies Center, Division of Hematology/Oncology\n","Associate Professor\n","Harvard Medical School"],"disclosure":""},{"name":"Cem Akin, MD, PhD","credentials":["Professor of Medicine \n","University of Michigan"],"disclosure":"Consultant/Advisory Boards: Deciphera [Mastocytosis]; Patara Pharma [Mastocytosis (Cromolyn)]; Novartis [Mastocytosis (Midostaurin)]. Patent Holder: LAD2 cell line [Mast cells]."},{"name":"Mary A Albrecht, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Macrene Alexiades, MD, PhD","credentials":["Associate Clinical Professor\n","Yale University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Serene Medical [Facial aesthetic laser treatments]; DUSA Pharmaceuticals Inc. [Photodynamic Therapy (Aminolevulinic acid HCl)]; DEKA Research and Development Corp. [Fractional lasers (Dermal optical thermolysis laser)]. Consultant/Advisory Boards: Allergan [Facial aesthetics (Botulinum toxin type A, hyaluronic acid fillers)]."},{"name":"Andrew F Alexis, MD, MPH","credentials":["Associate Professor\n","Icahn School of Medicine, Mt. Sinai St. Luke's and Roosevelt Hospitals"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan [Hyperpigmentation (Skin-brightening cream)]. Consultant/Advisory Board: Roche [Dissecting cellulitis (Isotretinoin)]; Amgen [Dissecting cellulitis (Etanercept)]; Galderma [Melasma (Hydroquinone, fluocinolone acetonide, tretinoin cream)]; Allergan [Hyperpigmentation (Skin-brightening cream)]."},{"name":"Patrick C Alguire, MD, FACP","credentials":["Senior Vice President Emeritus for Medical Education\n","American College of Physicians"],"disclosure":""},{"name":"Shawn Allen, MD","credentials":["Assistant Clinical Professor, Department of Dermatology\n","University of Colorado\n","Director, Dermatology Specialists of Boulder, PC Boulder, CO"],"disclosure":"Consultant/Advisory Boards: Galderma [Nerve injury (Botulinum toxin)]."},{"name":"Iris Amitay-Laish, MD","credentials":["Lecturer, Department of Dermatology\n","Rabin Medical Center, Beilinson Hospital, Petah Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"],"disclosure":""},{"name":"Karl E Anderson, MD, FACP","credentials":["Professor\n","The University of Texas Medical Branch"],"disclosure":"Grant/Research/Clinical Trial Support: Alnylam Pharmaceuticals [Acute porphyrias (RNAi therapy)]; Recordati Rare Disease [Acute porphyrias (Hemin)]; Mitsubishi Tanabe Pharma America [Protoporphyria]. Consultant/Advisory Boards: Alnylam Pharmaceuticals [Acute porphyrias (RNAi therapy)]; Recordati Rare Disease [Acute porphyrias (Hemin)]; Mitsubishi Tanabe Pharma America [Protoporphyria]; Moderna Therapeutics [Acute porphyrias]."},{"name":"Grant J Anhalt, MD","credentials":["Professor of Dermatology and Pathology\n","Johns Hopkins University, School of Medicine"],"disclosure":""},{"name":"Giuseppe Argenziano, MD","credentials":["Associate Professor and Coordinator of the Skin Cancer Unit\n","Arcispedale S. Maria Nuova IRCCS, Reggio Emilia"],"disclosure":""},{"name":"April W Armstrong, MD, MPH","credentials":["Associate Dean for Clinical Research\n","Department of Dermatology\n","University of Southern California"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen; AbbVie; Janssen; Eli Lilly and Company [Psoriasis (Etanercept, adalimumab, ustekinumab, ixekizumab)]. Speaker's Bureau: AbbVie; Eli Lilly and Company; Janssen [Psoriasis (Adalimumab, ixekizumab, guselkumab)]. Consultant/Advisory Boards: AbbVie; Janssen; Pfizer; Celgene; Novartis; Eli Lilly and Company; Sanofi; Regeneron [Psoriasis (Adalimumab, ustekinumab, tofacitinib, apremilast, tildrakizumab, ixekizumab, dupilumab)]."},{"name":"Kenneth A Arndt, MD","credentials":["Clinical Professor of Dermatology, Emeritus\n","Harvard Medical School"],"disclosure":""},{"name":"Stephanie J Arnold, FACD, MBBS (Hons), BSc (Hons)","credentials":["Consultant Dermatologist\n","Churchill Hospital Department of Dermatology, Oxford"],"disclosure":""},{"name":"Riccardo Asero, MD","credentials":["Head Ambulatorio di Allergologia\n","Clinica San Carlo, Paderno Dugnano (MI), Italy"],"disclosure":""},{"name":"Maryam Asgari, MD, MPH","credentials":["Associate Professor\n","Massachusetts General Hospital at Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Psoriasis (Anti-tumor necrosis factor-alpha inhibitor, immunosuppressants)]; Valeant [Atopic dermatitis (Pimecrolimus, topical corticosteroid, topical calcineurin inhibitor)]."},{"name":"Jon C Aster, MD","credentials":["Professor of Pathology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Regeneron [Hematologic malignancies (Notch inhibitors)]; Lilly [Hematologic malignancies (Notch inhibitors)]; Cellestia [Hematologic malignancies (Notch inhibitors)]; Anastasis [Hematologic malignancies (Notch inhibitors)]. Equity Ownership/Stock Options: Cellestia; Anastasis."},{"name":"Larry M Baddour, MD, FIDSA, FAHA","credentials":["Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Armita Bahrami, MD","credentials":["St. Jude Children’s Research Hospital\n","University of Tennessee Health Science Center"],"disclosure":""},{"name":"Yevgeniy Balagula, MD","credentials":["Assistant Professor\n","Division of Dermatology\n","Montefiore Medical Center"],"disclosure":""},{"name":"Aleena Banerji, MD","credentials":["Associate Professor\n","Training Program Director\n","Massachusetts General Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [Hereditary angioedema (Icatibant)]; CSL [Hereditary angioedema (Cinryze, Berinert)]. Consultant/Advisory Boards: Shire [Hereditary angioedema (Icatibant)]; Alnylam [Hereditary angioedema]; CSL [Hereditary angioedema (Berinert)]; Biocryst [Hereditary angioedema (No product FDA approved yet)]."},{"name":"Benjamin Barankin, MD, FRCPC","credentials":["Dermatologist, Medical Director \n","Toronto Dermatology Centre, Toronto, Canada"],"disclosure":""},{"name":"Raymond L Barnhill, MD","credentials":["Professor of Pathology\n","Department of Pathology, Institut Curie"],"disclosure":"Grant/Research/Clinical Trial Support: Myriad Genetics, Inc. [Melanoma (Gene signature analysis)]. Consultant/Advisory Boards: Myriad Genetics, Inc. [Melanoma (Gene signature analysis)]."},{"name":"Elma D Baron, MD","credentials":["Professor of Dermatology\n","Case Western Reserve University"],"disclosure":"Grant/Research/Clinical Trial Support: Soligenix, Inc. [CTCL (Hypericin for PDT)]. Consultant/Advisory Boards: Biofronterra [PDT (ALA patch for PDT)]."},{"name":"Priya Batra, MD","credentials":["Attending physician\n","Mt. Sinai Hospital"],"disclosure":""},{"name":"Johann Bauer, MD","credentials":["Professor and Chair of Dermatology and Venereology\n","Paracelsus Medical University Salzburg"],"disclosure":"Equity Ownership/Stock Options: Diaderm [Epidermolysis bullosa (Diacerein)]."},{"name":"Christian L Baum, MD","credentials":["Assistant Professor, Department of Dermatology\n","Mayo Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Dermatology Foundation [Cutaneous squamous cell carcinoma, chronic lymphocytic leukemia, non-Hodgkin lymphoma]."},{"name":"Theresa Becker, DO","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical School\n","Medical Director, Pediatric Programs Lahey Beverly\n","Executive Network Director\n","Division of Emergency Medicine"],"disclosure":""},{"name":"Latanya T Benjamin, MD","credentials":["Pediatric Dermatologist\n","Joe DiMaggio Children's Hospital"],"disclosure":""},{"name":"Wilma Bergfeld, MD","credentials":["Professor of Dermatology and Pathology\n","Cleveland Clinic\n","Clinical Associate Professor of Dermatology\n","Lerner Medical School and Case Western Reserve Medical School"],"disclosure":"Consultant/Advisory Boards: Johnson & Johnson [Hair loss (Minoxidil)]; Samumed [Topical investigational study]; Incyte [Topical investigational study]."},{"name":"Diane Berson, MD","credentials":["Assistant Clinical Professor of Dermatology\n","Weill Medical College of Cornell University"],"disclosure":"Consultant/Advisory Boards: Allergan [Acne (Antioxidants and anti-inflammatory)]; Merz [Acne (Antioxidants and anti-inflammatory)]; Illumask [Acne (Antioxidants and anti-inflammatory)]; Procter and Gamble [Cosmecueticals]; TopMD [Acne (Antioxidants and anti-inflammatory)]."},{"name":"Neal Bhatia, MD","credentials":["Director of Clinical Dermatology\n","Therapeutics Clinical Research"],"disclosure":"Grant/Research/Clinical Trial Support: Viamet [Onychomycosis]. Speaker's Bureau: Anacor, Valeant [Onychomycosis]. Consultant/Advisory Boards: Anacor, Valeant [Onychomycosis]."},{"name":"Andreas J Bircher, MD","credentials":["Professor of Dermatology\n","University Hospital, Basel, Switzerland"],"disclosure":"Consultant/Advisory Boards: Accord Healthcare; Acino Pharma; Arrow Génériques; Claris Lifesciences; Generis Farmacéutica; Genfarma/Genéricos Españoles; Laboratoires Sterop; MEDICE Arzneimittel Pütter; Mesama Consulting; Mylan; Orifarm Generics; PanMedica; Pharmachemie; Pharmacosmos; Rafarm; Sandoz; Sanofi Aventis Group; Vifor Pharma [Hypersensitivity reactions (Intravenous iron products)]."},{"name":"Andrew Blauvelt, MD, MBA","credentials":["President and Investigator\n","Oregon Medical Research Center"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Psoriasis (Adalimumab and risankizumab)]; Amgen [Psoriasis (Etanercept)]; Boehringer Ingelheim Pharmaceuticals [Psoriasis (Risankizumab)]; Celgene Corporation [Psoriasis (Apremilast)]; Dermira [Psoriasis (Certolizumab pegol)]; Eli Lily [Psoriasis (Ixekizumab and baricitinib)]; Genentech [Atopic dermatitis (Lebrikizumab)]; GlaxoSmithKline [Atopic dermatitis (Mepolizumab)]; Janssen Pharmaceuticals [Psoriasis (Ustekinumab and guselkumab)]; Leo Pharma [Atopic dermatitis (Tralokinumab)]; Merck [Psoriasis (Tildrakizumab)]; Novartis [Psoriasis (Secukinumab)]; Pfizer [Psoriasis (Tofacitinib)]; Regeneron Pharmaceuticals [Atopic dermatitis (Dupilumab)]; Sandoz [Psoriasis (Biosimilar adalimumab)]; Sanofi Genzyme [Atopic dermatitis (Dupilumab)]; Sun Pharmaceutical Industries [Psoriasis (Tildrakizumab)]; UCB [Psoriasis (Certolizumab pegol and bimekizumab)]; Valeant Pharmaceuticals International [Psoriasis (Brodalumab)]. Speaker's Bureau: Eli Lily [Psoriasis (Ixekizumab and baricitinib)]; Janssen Pharmaceuticals [Psoriasis (Ustekinumab and guselkumab)]; Regeneron Pharmaceuticals [Atopic dermatitis (Dupilumab)]; Sanofi Genzyme [Atopic dermatitis (Dupilumab)]. Consultant/Advisory Boards: AbbVie [Psoriasis (Adalimumab and risankizumab)]; Amgen [Psoriasis (Etanercept)]; Boehringer Ingelheim Pharmaceuticals [Psoriasis (Risankizumab)]; Celgene Corporation [Psoriasis (Apremilast)]; Dermira [Psoriasis (Certolizumab pegol)]; Eli Lily [Psoriasis (Ixekizumab and baricitinib)]; Genentech [Atopic dermatitis (Lebrikizumab)]; GlaxoSmithKline [Atopic Dermatitis (Mepolizumab)]; Janssen Pharmaceuticals [Psoriasis (Ustekinumab and guselkumab)]; Leo Pharma [Atopic dermatitis (Tralokinumab)]; Merck [Psoriasis (Tildrakizumab)]; Novartis [Psoriasis (Secukinumab)]; Pfizer [Psoriasis (Tofacitinib)]; Regeneron Pharmaceuticals [Atopic dermatitis (Dupilumab)]; Sandoz [Psoriasis (Biosimilar adalimumab)]; Sanofi Genzyme [Atopic dermatitis (Dupilumab)]; Sun Pharmaceutical Industries [Psoriasis (Tildrakizumab)]; UCB [Psoriasis (Certolizumab pegol and bimekizumab)]; Valeant Pharmaceuticals International [Psoriasis (Brodalumab)]."},{"name":"Andreas Blum, MD, MSc","credentials":["Associate Professor of Dermatology - Faculty of Medicine\n","University of Tuebingen, Germany"],"disclosure":""},{"name":"John B Bodensteiner, MD","credentials":["Senior Associate Consultant in Child and Adolescent Neurology\n","Mayo Clinic College of Medicine"],"disclosure":"Consultant/Advisory Boards: Ionis (Isis) Pharmaceuticals [SMA DSMB]; American Board of Psychiatry and Neurology [Director]."},{"name":"Kim Bohjanen, MD","credentials":["Associate Professor\n","University of Minnesota"],"disclosure":""},{"name":"Jean L Bolognia, MD","credentials":["Professor of Dermatology\n","Yale University School of Medicine"],"disclosure":""},{"name":"Alexandro Bonifaz, MD","credentials":["Professor and Senior Researcher\n","Hospital General de México"],"disclosure":""},{"name":"Laurence M Boon, MD, PhD","credentials":["Coordinator of the Center for Vascular Malformations\n","Division of Plastic Surgery\n","Cliniques Universitaires St Luc, Catholic University of Louvain"],"disclosure":""},{"name":"Jerry D Brewer, MD","credentials":["Assistant Professor of Dermatology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Sylvia Brice, MD","credentials":["Associate Professor of Dermatology\n","University of Colorado Denver, School of Medicine"],"disclosure":""},{"name":"Bruce A Brod, MD","credentials":["Clinical Professor of Dermatology\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Robert T Brodell, MD","credentials":["Professor and Chair, Department of Dermatology\n","Professor of Pathology\n","University of Mississippi Medical Center"],"disclosure":""},{"name":"Anna L Bruckner, MD","credentials":["Associate Professor of Dermatology and Pediatrics\n","University of Colorado School of Medicine, Aurora, CO"],"disclosure":""},{"name":"Giovanna Brunasso, MD","credentials":["First Level Medical Director\n","Department of Dermatology\n","Galliera Hospital"],"disclosure":""},{"name":"Bettina Burger, DSc","credentials":["Head of Research Laboratory of Dermatology\n","University of Basel"],"disclosure":""},{"name":"Antonio C Buzaid, MD","credentials":["General Medical Director, \n","Centro Oncologico Antonio Ermirio de Moraes, \n","BP de Sao Paulo, Brazil\n","Steering Committee Member,\n","Centro Oncológico do Hospital Israelita Albert Einstein, \n","Sao Paulo, Brazil"],"disclosure":""},{"name":"David Cabral, MBBS, FRCPC","credentials":["Clinical Professor of Pediatrics, Head, Division of Rheumatology, Department of Pediatrics\n","University of British Columbia"],"disclosure":""},{"name":"Valerie D Callender, MD, FAAD","credentials":["Associate Professor of Dermatology\n","Howard University College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan [Acne/PIH, melasma (Tazarotene)]; Galderma [Acne/PIH, melasma (4%HQ/tretinoin/fluocinolone)]; Bayer [Acne/PIH, melasma (Azelaic acid 15% gel)]. Consultant/Advisory Boards: Allergan [Acne (Topical dapsone)]; Galderma [Acne (Adapalene/BPO)]."},{"name":"Kristina Callis Duffin, MD","credentials":["Section Editor — Psoriasis\n","Associate Professor, Department of Dermatology\n","University of Utah"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Psoriasis (Etanercept and brodalumab)]; AbbVie Inc. [Psoriasis (Adalimumab)]; Celgene Corporation [Psoriasis (Apremilast)]; Eli Lilly and Company [Psoriasis (Ixekizumab and baricitinib)]; Novartis [Psoriasis (Secukinumab)]; Bristol-Myers Squibb Company [Psoriasis (Abatacept)]; Pfizer Inc. [Psoriasis (Tofacitinib)]; Janssen Pharmaceutica [Psoriasis (Ustekinumab, guselkumab, golimumab, and infliximab)]; Stiefel Laboratories [Psoriasis (Calcipotriene)]. Consultant/Advisory Boards: Amgen [Psoriasis (Etanercept and brodalumab)]; AbbVie Inc. [Psoriasis (Adalimumab)]; Celgene Corporation [Psoriasis (Apremilast)]; Eli Lilly and Company [Psoriasis (Ixekizumab and baricitinib)]; Novartis [Psoriasis (Secukinumab)]; Bristol-Myers Squibb Company [Psoriasis (Abatacept)]; Pfizer Inc. [Psoriasis (Tofacitinib)]; Janssen Pharmaceutica [Psoriasis (Ustekinumab, guselkumab, golimumab, and infliximab)]; Stiefel Laboratories [Psoriasis (Calcipotriene)]."},{"name":"Judith R Campbell, MD","credentials":["Professor of Pediatric Infectious Diseases\n","Baylor College of Medicine"],"disclosure":""},{"name":"Adela Rambi G Cardones, MD","credentials":["Associate Professor\n","Duke University"],"disclosure":""},{"name":"Alastair Carruthers, FRCPC","credentials":["Clinical Professor, Department of Dermatology and Skin Science\n","University of British Columbia"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan, Inc. [BoNTA and fillers (OnabotulinumtoxinA, hyaluronic acid gel); Merz and Revance [BoNTA and fillers (IncobotulinumtoxinA, dermal filler, calcium hydroxylapatite, injectable botulinum toxin investigational product)]. Consultant/Advisory Boards: Kythera BioPharma [Submental fullness (Deoxycholic acid)]; Allergan, Inc. [Submental fullness (Deoxycholic acid)]; Merz [Submental fullness (Deoxycholic acid)]; Revance [Neuromodulators (Neuromodulators)]. Grant/Research/Clinical Trial Support (Spouse): Allergan Pharmaceuticals [Neuromodulators and fillers (OnabotulinumtoxinA)]; Merz USA and Merz GmBH [Neuromodulators and fillers (Hyaluronic acid)]; Kythera BioPharma [Sodium deoxycholate (Deoxycholate)]. Consultant/Advisory Boards (Spouse): Allergan Pharmaceuticals [Neuromodulators and fillers (OnabotulinumtoxinA)]; Merz USA and Merz GmBH [Neuromodulators and fillers (Hyaluronic acid)]; Kythera BioPharma [Sodium deoxycholate (Deoxycholate)]."},{"name":"Jean Carruthers, MD, FRCSC","credentials":["Clinical Professor, Department of Ophthalmology and Visual Sciences\n","University of British Columbia"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan Pharmaceuticals [Neuromodulators (OnabotulinumtoxinA, sodium deoxycholate)]; Revance Therapeutics Inc. [Neuromodulators (DaxibotulinumtoxinA)]; Alphaeon Corporation [Neuromodulators (BotulinumtoxinA)]; Zeltiq Aesthetics Inc. [Arm/body sculpting (Cryopolysis)]. Grant/Research/Clinical Trial Support (Spouse): Allergan Pharmaceuticals [Neuromodulators (OnabotulinumtoxinA, sodium deoxycholate)]; Revance Therapeutics Inc. [Neuromodulators (DaxibotulinumtoxinA)]; Alphaeon Corporation [Neuromodulators (BotulinumtoxinA)]. Consultant/Advisory Boards: Allergan Pharmaceuticals [Neuromodulators (OnabotulinumtoxinA, sodium deoxycholate)]; Bonti [Neuromodulators (Botulinum toxin E)]; Revance [Neuromodulators (DaxibotulinumtoxinA)]; Alphaeon [Neuromodulators (BotulinumtoxinA)]; Zeltiq Aesthetics Inc. [Arm/body sculpting (Cryopolysis)]. Consultant/Advisory Boards (Spouse): Allergan Pharmaceuticals [Neuromodulators (OnabotulinumtoxinA, sodium deoxycholate)]; Revance Therapeutics Inc. [Neuromodulators (DaxibotulinumtoxinA)]; Alphaeon Corporation [Neuromodulators (BotulinumtoxinA)]."},{"name":"Mariana C Castells, MD, PhD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Felipe Bochnia Cerci, MD","credentials":["Assistant Professor\n","Department of Dermatology, Hospital Santa Casa de Curitiba"],"disclosure":""},{"name":"Amy Y-Y Chen, MD, FAAD","credentials":["Assistant Professor, Department of Dermatology\n","University of Connecticut School of Medicine"],"disclosure":""},{"name":"Mei Chen, PhD","credentials":["Professor and Director of Research - Department of Dermatology\n","University of Southern California"],"disclosure":""},{"name":"Karen A Chernoff, MD","credentials":["Assistant Professor of Dermatology and Pediatrics\n","Weill Cornell Medical College"],"disclosure":""},{"name":"Anna L Chien, MD","credentials":["Assistant Professor of Dermatology\n","Johns Hopkins School of Medicine"],"disclosure":""},{"name":"Keith Choate, MD, PhD","credentials":["Associate Professor of Dermatology, Genetics, and Pathology\n","Yale University School of Medicine"],"disclosure":"Speaker's Bureau: AbbVie [Psoriasis (Adalimumab)]; Janssen [Psoriasis (Ustekinumab)]."},{"name":"Chia-Yu Chu, MD, PhD","credentials":["Associate Professor - Department of Dermatology\n","National Taiwan University Hospital"],"disclosure":""},{"name":"Derek H Chu, MD","credentials":["Clinical Assistant Professor\n","Department of Dermatology, Stanford University"],"disclosure":""},{"name":"Antonio A T Chuh, MD, FRCP, FRCPCH","credentials":["Adjunct Clinical Assistant Professor\n","JC School of Public Health\n","The Chinese University of Hong Kong and the Prince of Wales Hospital Hong Kong"],"disclosure":""},{"name":"Marco Cicardi, MD","credentials":["Professor of Medicine\n","Università degli Studi di Milano, Italy"],"disclosure":"Grant/Research/Clinical Trial Support: Shire; CSL Behring; Pharming; BioCryst [Hereditary angioedema (Icatibant, plasma-derived C1INH, recombinant human C1INH, lanadelumab)]. Speaker's Bureau: Shire; CSL Behring; Pharming [Hereditary angioedema (Icatibant, plasma-derived C1INH, recombinant human C1INH)]. Consultant/Advisory Boards: Shire; CSL Behring; BioCryst; Pharvaris; KalVista [Hereditary angioedema (Lanadelumab, subcutaneous C1INH, avoralstat, oral anti-bradykinin, oral anti-kallikrein)]."},{"name":"Jennie Clarke, MD","credentials":["Associate Professor of Dermatology\n","University of Utah Health Science Center"],"disclosure":""},{"name":"Susan M Cooper, MB ChB, MRCGP, FRCP, MD","credentials":["Consultant Dermatologist and Honorary Senior Clinical Lecturer\n","Oxford University Hospitals"],"disclosure":""},{"name":"Rosamaria Corona, MD, DSc","credentials":["Deputy Editor — Dermatology"],"disclosure":""},{"name":"Edward W Cowen, MD, MHSc","credentials":["Senior Clinician and Head, Dermatology Consultation Service\n","Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases\n","National Institutes of Health"],"disclosure":""},{"name":"Clara Curiel-Lewandrowski, MD","credentials":["Associate Professor of Dermatology\n","Arizona Cancer Center, University of Arizona"],"disclosure":""},{"name":"Mark V Dahl, MD","credentials":["Section Editor — Acne and Rosacea\n","Professor Emeritus\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Mark DP Davis, MD","credentials":["Professor of Dermatology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Fatma Dedeoglu, MD","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Christopher P Denton, MD","credentials":["Professor of Experimental Rheumatology\n","Royal Free Hospital, London"],"disclosure":"Grant/Research/Clinical Trial Support: GlaxoSmithKline [Scleroderma, pulmonary hypertension (Ambrisentan, epoprostenol)]; Inventiva [Scleroderma, pulmonary hypertension]; Roche [Scleroderma, pulmonary hypertension]; CSL Behring [Scleroderma, pulmonary hypertension]; Sanofi-Aventis [Scleroderma]. Consultant/Advisory Boards: GlaxoSmithKline [Scleroderma, pulmonary hypertension (Ambrisentan, epoprostenol)]; Inventiva [Scleroderma, pulmonary hypertension]; Roche [Scleroderma, pulmonary hypertension]; Actelion [Scleroderma, pulmonary hypertension (Bosentan, macitentan)]; Boehringer Ingelheim [Scleroderma]; Bayer [Scleroderma, pulmonary hypertension (Riociguat)]; EMD Serono [Scleroderma]; Medac [Scleroderma]."},{"name":"Jennifer A DeSimone, MD","credentials":["Assistant Professor\n","Georgetown University Department of Dermatology\n","Director, Cutaneous Lymphoma Program and Transplant Dermatology\n","Inova Melanoma and Skin Cancer Center"],"disclosure":""},{"name":"Clio Dessinioti, MD","credentials":["Attending Physician\n","Department of Dermatology, Medical School, University of Athens, A.Syggros Hospital"],"disclosure":""},{"name":"John P Dice, MD","credentials":["Allergy and Immunology\n","Private Practice"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech; Sanofi; TEVA Pharmaceuticals; AstraZeneca; GlaxoSmithKline; Perrigo; DBV Technologies. Speaker's Bureau: TEVA Pharmaceuticals [Asthma, allergy (Beclomethasone dipropionate, albuterol sulfate)]."},{"name":"Jeff Donovan, MD, PhD","credentials":["Assistant Professor of Medicine\n","University of Toronto"],"disclosure":""},{"name":"Jeffrey S Dover, MD, FRCPC","credentials":["Section Editor — Cosmetic Dermatology\n","Associate Clinical Professor of Dermatology\n","Yale University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan; Evolus; Valeant Pharmaceuticals [Neuromodulators, fillers]; Cutera; Cynosure; Lumenis; Syneron; Valeant Pharmaceuticals [Lasers, lights]; Merz [Toxin, filler]; Shaser Bioscience [Intense pulse light hair removal (Hair removal device)]; Zeltiq Aesthetics [Body contouring (Fat loss system)]; Revance [Neuromodulator]; Sienna [Lasers]. Consultant/Advisory Boards: Maison de Beaute; Web MD; Sky Biodevices; Syneron; Shaser Bioscience; Cutera; Cynosure; Lumenis; Valeant Pharmaceuticals [Lasers, lights]; Kythera Biopharmaceuticals [Fat saponification]; Myoscience [Neuromuscular]; Topokine Therapeutics [Fat modulation (Biologics)]; Zeltiq Aesthetics [Body contouring (Fat loss system)]; Valeant Pharmaceuticals [Fillers, toxin]; Sienna [Lasers]. Equity Ownership/Stock Options: CVS/Skin Effects [Skin care]; Shaser Bioscience [Intense pulse light hair removal (Hair removal device)]; Sky Biodevices [Skin cancer screening]. Other Financial Interest: Cynosure; Lumenis; Syneron [Use of equipment (Lasers, lights)]."},{"name":"Kathleen A Downey, MD","credentials":["Associate Clinical Professor of Family Medicine\n","University of Cincinnati"],"disclosure":""},{"name":"Jonathan A Dyer, MD","credentials":["Assistant Professor of Dermatology and Child Health - Department of Dermatology\n","University of Missouri"],"disclosure":"Grant/Research/Clinical Trial Support: Crown Therapeutics [Ichthyosis vulgaris (Topical lotion)]."},{"name":"Benjamin D Ehst, MD, PhD","credentials":["Clinical Associate Professor\n","Oregon Health & Science University, Portland, OR"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen Pharmaceutica; AbbVie; Pfizer; Eli Lilly and Company; UCB; Boehringer Ingelheim; Novartis; Merck; Dermira [Psoriasis (Tofacitinib, ixekizumab, guselkumab, bimekizumab, risankizumab, secukinumab, tildrakizumab, certolizumab pegol)]. Speaker's Bureau: Novartis; Eli Lilly and Company [Psoriasis (Secukinumab, ixekizumab)]. Consultant/Advisory Boards: Novartis; Eli Lilly and Company [Psoriasis (Secukinumab, ixekizumab)]."},{"name":"Craig A Elmets, MD","credentials":["Section Editor — Photodermatology\n","Professor and Chair of Dermatology\n","University of Alabama at Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: Solgenix [CTCL (SGX301)]; Kyowa Hakko USA [CTCL (Mogamulizumab)]; CA Assn of Wine Growers [Photoprotection (Grapes)]; Ferndale Labs [Photoprotection (Polypodium leukotomos)]; Elorac [CTCL (Topical Naloxone]); Idera [Dermatomyositis (IMO-8400)]. Consultant/Advisory Boards: Ferndale Labs [Photoprotection (Polypodium leukotomos)]; Astellas Pharma US [Data Safety Monitoring Board - Atopic Dermatitis (Tacrolimus)]. Equity Ownership/Stock Options: Aevi Genomic Medicine (Gene therapy); Vaxin (Topical vaccines)."},{"name":"Dirk M Elston, MD","credentials":["Professor and Chair, Department of Dermatology and Dermatologic Surgery\n","Medical University of South Carolina"],"disclosure":""},{"name":"S Jean Emans, MD","credentials":["Mary Allen Avery Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Rüdiger Eming, MD","credentials":["Senior Physician and Group Leader - Department of Dermatology and Allergology\n","Philipps-Universität, Marburg Germany"],"disclosure":"Grant/Research/Clinical Trial Support: Fresenius Medical Care [Pemphigus (Immunosorba, Globaffin)]; Biotest [Autoimmune blistering diseases (Immunoglobulins)]. Speaker's Bureau: Fresenius Medical Care [Pemphigus (Immunosorba, Globaffin)]; Biotest [Autoimmune blistering diseases (Immunoglobulins)]; Novartis [Psoriasis]."},{"name":"Sara B Fazio, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Brian M Feldman, MD, MSc, FRCPC","credentials":["Professor of Pediatrics\n","University of Toronto"],"disclosure":"Other Financial Interest: Pfizer; BMS; Novartis; Optum; Ability [DSMB member for JIA studies]."},{"name":"Steven R Feldman, MD, PhD","credentials":["Professor\n","Wake Forest School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Galderma [Psoriasis (Clobetasol, calcitriol)]; National Biological Corporation [Psoriasis (Phototherapy equipment)] Pfizer [Psoriasis (Tofacitinib)]; Novartis [Psoriasis (Secukinumab)]; Lilly [Psoriasis (Ixekizumab)]; Taro [Psoriasis (Desoximetasone)]. Speaker's Bureau: Janssen [Psoriasis (Ustekinumab, infliximab, golimumab)]; Celgene [Psoriasis (Apremilast)]; Novartis [Psoriasis (Secukinumab)]; Lilly [Psoriasis (Ixekizumab)] Pfizer [Psoriasis (tofacitinib)]; Valeant [Psoriasis, (brodalumab)]. Consultant/Advisory Boards: Galderma [Psoriasis (Clobetasol, calcitriol)]; GSK/Stiefel [Psoriasis (Acitretin)]; Leo Pharma [Psoriasis (Betamethasone, calcipotriene)]; Celgene [Psoriasis (Apremilast)]; Pfizer [Psoriasis (Tofacitinib)]; AbbVie [Psoriasis (Adalimumab)]; Merck [Psoriasis]; Valeant [Psoriasis (Brodalumab)]; Lilly [Psoriasis (Ixekizumab)]."},{"name":"Alisa N Femia, MD","credentials":["Assistant Professor \n","The Ronald O. Perelman Department of Dermatology\n","New York University Langone Medical Center"],"disclosure":""},{"name":"Kristen H Fernandez, MD","credentials":["Assistant Professor\n","University of Missouri, Columbia"],"disclosure":""},{"name":"Nicole Fett, MD","credentials":["Associate Professor\n","Oregon Health and Science University"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Dermatomyositis (Interferon, beta 1, fibroblast blocker)]; F. Hoffmann-La Roche [Pemphigus vulgaris (Rituximab, mycophenolate mofetil)]."},{"name":"Andrew Fontenot, MD","credentials":["Henry N. Claman Professor of Medicine, Division Head, Allergy and Clinical Immunology\n","University of Colorado, School of Medicine"],"disclosure":""},{"name":"Stephen Foster, MD","credentials":["Clinical Professor of Ophthalmology\n","Harvard Medical School"],"disclosure":""},{"name":"Fabio Francesconi, MD","credentials":["Assistant Professor of Dermatology\n","Amazon Federal University - Medicine\n","Clinical Researcher; Coordinator - Dermatology Residence Program\n","Tropical Medicine Foundation Dr. Heitor Vieira Dourado"],"disclosure":""},{"name":"Michael M Frank, MD","credentials":["Samuel L. Katz Professor of Pediatrics\n","Duke University Medical Center"],"disclosure":"Consultant/Advisory Boards: BioCryst [Data and safety monitoring board hereditary angioedema drugs]; Shire [Data and safety monitoring board hereditary angioedema drugs]."},{"name":"Anthony F Fransway, MD","credentials":["Associates in Dermatology MD's, LLC\n","Fort Myers, FL"],"disclosure":""},{"name":"Arnold S Freedman, MD","credentials":["Section Editor — Lymphoproliferative Disorders\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Kahr Therapeutics [SAB]. Other Financial Interest: Novartis [DMB (Ofatumumab)]; Bayer [DMB (Bayer 17833)]."},{"name":"Ilona J Frieden, MD","credentials":["Professor of Dermatology and Pediatrics\n","University of California, San Francisco"],"disclosure":"Consultant/Advisory Boards: Pierre Fabre Dermatology [Infantile hemangiomas (Propranolol liquid formulation)]."},{"name":"Maxwell A Fung, MD","credentials":["Professor of Clinical Dermatology and Pathology\n","Department of Dermatology\n","University of California Davis School of Medicine"],"disclosure":""},{"name":"Sheila Galbraith, MD","credentials":["Mayo Clinic Health System\n","Eau Claire, Wisconsin"],"disclosure":""},{"name":"Amit Garg, MD, FAAD","credentials":["Professor - Department of Dermatology\n","Donald and Barbara Zucker School of Medicine at Hofstra/Northwell"],"disclosure":"Grant/Research/Clinical Trial Support: Merk [Alzheimer disease (Drug in development)]; AbbVie [Hidradenitis suppurativa (Adalimumab)]. Consultant/Advisory Boards: AbbVie [Hidradenitis suppurativa (Adalimumab)]; Asana Biosciences [Atopic dermatitis]."},{"name":"Anthony Gaspari, MD","credentials":["Chief, Section of Dermatology\n","Lancaster General Hospital"],"disclosure":""},{"name":"Alan C Geller, RN, MPH","credentials":["Senior Lecturer\n","Social and Behavioral Sciences\n","Harvard School of Public Health"],"disclosure":""},{"name":"Shamir Geller, MD","credentials":["Senior physician - Department of Dermatology at Tel Aviv Sourasky Medical Center\n","Tel Aviv University's Sackler Medical School"],"disclosure":""},{"name":"Jeffrey E Gershenwald, MD, FACS","credentials":["Professor of Surgery and Cancer Biology\n","The University of Texas MD Anderson Cancer Center"],"disclosure":"Consultant/Advisory Boards: Merck [Melanoma therapy (Pembrolizumab, interferonxx)]."},{"name":"Larisa J Geskin, MD","credentials":["Associate Professor of Dermatology in Medicine\n","Columbia University"],"disclosure":""},{"name":"David J Goldberg, MD","credentials":["Clinical Professor of Dermatology and Director of Laser Research \n","Mount Sinai School of Medicine, New York, NY"],"disclosure":""},{"name":"Lynne J Goldberg, MD","credentials":["Professor of Dermatology and Pathology and Laboratory Medicine\n","Boston University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Allergan [Hair growth]; Living Proof."},{"name":"Gary Goldenberg, MD","credentials":["Assistant Professor of Dermatology and Pathology\n","Mount Sinai School of Medicine\n","Medical Director of the Dermatology Faculty Practice"],"disclosure":""},{"name":"Ronald Goldner, MD","credentials":["Clinical Professor of Dermatology\n","University of Maryland Baltimore, School of Medicine"],"disclosure":""},{"name":"Adam O Goldstein, MD, MPH","credentials":["Professor\n","Department of Family Medicine\n","University of North Carolina at Chapel Hill"],"disclosure":""},{"name":"Beth G Goldstein, MD","credentials":["Adjunct Clinical Assistant Professor\n","Department of Dermatology\n","University of North Carolina at Chapel Hill"],"disclosure":""},{"name":"Erika Gonzalez-Reyes, MD","credentials":["Associate Professor of Pediatrics\n","Baylor College of Medicine"],"disclosure":"Speaker’s Bureau: Novartis (Omalizumab therapy). Consultant/Advisory Boards\t: Genentech (Omalizumab therapy)."},{"name":"Carmen Gota, MD","credentials":["Orthopedic and Rheumatologic Institute at Cleveland Clinic\n","Center for Vasculitis Care and Research at Cleveland clinic"],"disclosure":""},{"name":"Jason Gotlib, MD, MS","credentials":["Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Mastocytosis (Midostaurin)]; NIH/NCI [Advanced systemic mastocytosis/mast cell leukemia (Brentuximab vedotin)]; NIH/NCI [Systemic mastocytosis (Ibrutinib)]; Seattle Genetics [Advanced systemic mastocytosis/mast cell leukemia (Brentuximab vedotin)]; Pharmacyclics [Systemic mastocytosis (Ibrutinib)]; Stemline Therapeutics, Inc [High-risk myeloproliferative neoplasms (SL-401)]. Consultant/Advisory Boards: Deciphera Pharmaceuticals [Mastocytosis]; Blueprint Medicines [Mastocytosis]; Plexxikon [Mastocytosis]."},{"name":"Emmy Graber, MD, MBA","credentials":["Clinical Instructor\n","Northeastern University"],"disclosure":"Speaker's Bureau: Allergan [Acne (Topical dapsone)]. Consultant/Advisory Boards: Hovione [Acne (Topical minocycline)]."},{"name":"Pearl E Grimes, MD","credentials":["Clinical Professor of Dermatology\n","University Of California, Los Angeles"],"disclosure":""},{"name":"Deepti Gupta, MD","credentials":["Assistant Professor of Pediatrics (Dermatology)\n","Department of Pediatrics and Division of Dermatology\n","Seattle Children's Hospital\n","University of Washington School of Medicine"],"disclosure":""},{"name":"Autumn Chandler Guyer, MD","credentials":["Assistant Clinical Professor of Medicine\n","University of California San Francisco"],"disclosure":""},{"name":"M. Tye Haeberle, MD","credentials":["Clinical Instructor\n","Division of Dermatology, University of Louisville"],"disclosure":""},{"name":"Russell P Hall, III, MD","credentials":["J Lamar Callaway Professor and Chair, Department of Dermatology\n","Duke University Medical Center"],"disclosure":""},{"name":"Allan Halpern, MD, MSc","credentials":["Member\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":"Consultant/Advisory Boards: Canfield Scientific, Inc. [Atypical nevi (Photography systems)]; Caliber Imaging and Diagnostics [Atypical nevi (Confocal microscopes)]."},{"name":"Jennifer L Hand, MD","credentials":["Section Editor — Genodermatoses\n","Associate Professor of Dermatology, Medical Genetics, and Pediatrics\n","Mayo Clinic, Rochester, MN"],"disclosure":""},{"name":"Evangeline B Handog, MD","credentials":["Chair, Department of Dermatology\n","Asian Hospital and Medical Center"],"disclosure":""},{"name":"Allison M Hanlon, MD","credentials":["Assistant Professor\n","Division of Dermatology\n","Mohs Dermatologic Surgery\n","Department of Medicine\n","Vanderbilt University"],"disclosure":""},{"name":"Cristina Has, MD","credentials":["Department of Dermatology,\n","Medical Center - University of Freiburg, Germany"],"disclosure":""},{"name":"Jason E Hawkes, MD","credentials":["Instructor in Clinical Investigation\n","Laboratory for Investigative Dermatology, Rockefeller University"],"disclosure":""},{"name":"Elena B Hawryluk, MD, PhD","credentials":["Assistant Professor\n","Harvard Medical School"],"disclosure":"Patent Holder (Spouse): Foundation Medicine [Genetic testing for cancer]. Employment (Spouse): Foundation Medicine [Genetic testing for cancer]; Gritstone Oncology [Personalized cancer immunotherapy]. Equity Ownership/Stock Options (Spouse): Foundation Medicine [Genetic testing for cancer]; Gritstone Oncology [Personalized cancer immunotherapy]."},{"name":"Michael Hertl, MD","credentials":["Professor and Chairman - Department of Dermatology and Allergology\n","Philipps-Universität, Marburg Germany"],"disclosure":"Grant/Research/Clinical Trial Support: Biotest Pharmaceuticals Corporation [Pemphigus (Immunoglobulin G)]; Fresenius [Pemphigus (Immunoadsorption device)]. Speaker’s Bureau: Janssen-Cilag [General immunodermatology, bullous diseases (Ustekinumab)]. Consultant/Advisory Boards: Novartis [Psoriasis, immunodermatology, academic mentoring programs (Secukinumab)]."},{"name":"Whitney A High, MD","credentials":["Associate Professor of Dermatology and Dermatopathology\n","University of Colorado School of Medicine"],"disclosure":""},{"name":"Emmilia Hodak, MD","credentials":["Head, Department of Dermatology\n","Rabin Medical Center, Beilinson Hospital, Petah Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"],"disclosure":"Speaker's Bureau: Actelion Pharmaceuticals Ltd [Mycosis fungoides (Topical mechlorethamine, nitrogen mustard)]. Consultant/Advisory Boards: Actelion Pharmaceuticals Ltd [Mycosis fungoides (Topical mechlorethamine, nitrogen mustard)]."},{"name":"Daniel Hohl, MD","credentials":["Full Professor\n","Lausanne University Hospital"],"disclosure":""},{"name":"Herbert Hönigsmann, MD","credentials":["Professor of Dermatology, Emeritus Chairman \n","Medical University of Vienna"],"disclosure":""},{"name":"Richard T Hoppe, MD","credentials":["Professor of Radiation Oncology\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Maria Hordinsky, MD","credentials":["Section Editor — Hair and Scalp Disease\n","Chair and Professor - Department of Dermatology\n","University of Minnesota Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Incyte Corporation [Alopecia areata (Topical Janus kinase inhibitor)]; Allergan [Male pattern baldness (Setipiprant tablets)]; Pfizer [Alopecia areata (Oral Janus kinase inhibitor)]. Consultant/Advisory Boards: Concert Pharmaceuticals [Alopecia areata (Oral Janus kinase inhibitor)]; BiologicsMD [Alopecia, androgenetic alopecia (Hair cycle stimulator, subcutaneous injection)]; Bionz [Alopecia areata]. Other financial interest: Pantene Institute/Proctor & Gamble (Hair care products)."},{"name":"Kimberly A Horii, MD","credentials":["Professor of Pediatrics\n","University of Missouri-Kansas City School of Medicine, Children's Mercy Hospital"],"disclosure":""},{"name":"Steven Horwitz, MD","credentials":["Associate Attending\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene Corporation [mycosis fungoides (romidepsin)]; Millennium Pharmaceuticals/Takeda [Hodgkin lymphoma (brentuximab vedotin)]; Kyowa-Hakka-Kirin [mycosis fungoides (mogamulizumab)]; Seattle Genetics [Hodgkin lymphoma (brentuximab vedotin)]; Spectrum Pharmaceuticals [mycosis fungoides (pralatrexate)]; Forty-Seven; Infinity/Verastem; ADCT Therapeutics; Aileron Therapeutics. Consultant/Advisory Boards: Celgene Corporation; Millennium Pharmaceuticals/Takeda; Kyowa-Hakka-Kirin; Seattle Genetics; Forty-Seven; Infinity/Verastem; HUYA; BMA; Mundipharma."},{"name":"Eric W Hossler, MD","credentials":["Associate\n","Departments of Dermatology and Pathology\n","Geisinger Medical Center"],"disclosure":""},{"name":"William Howe, MD","credentials":["Assistant Clinical Professor\n","University of Colorado Denver School of Medicine"],"disclosure":""},{"name":"George J Hruza, MD","credentials":["Adjunct Professor of Dermatology and Otolaryngology\n","St. Louis University School of Medicine"],"disclosure":""},{"name":"Christopher Hull, MD","credentials":["Associate Professor, Department of Dermatology\n","University of Utah"],"disclosure":""},{"name":"C Scott Hultman, MD, MBA, FACS","credentials":["Ethel and James Valone Distinguished Professor of Surgery; Division Chief and Program Director\n","UNC Plastic Surgery"],"disclosure":""},{"name":"Shannon Humphrey, MD, FRCPC, FAAD","credentials":["Clinical Assistant Professor, Department of Dermatology and Skin Science\n","University of British Columbia"],"disclosure":"Grant/Research Support: Allergan [Injectable drug targeting submental fullness (Deoxycholic acid)]; Zeltiq [Arm/body sculpting (Cryolipolysis)]; Cutanea Life Sciences [Rosacea (Topical treatment)]; Revance Therapeutics; Evolus [Acne (Neuromodulator)]. Speaker's Bureau: Allergan [Cosmetic dermatology (Neuromodulators, fillers)]; Galderma; L'Oreal [Acne, rosacea (Topical acne and rosacea treatments)]. Consultant/Advisory Boards: Allergan [Cosmetic dermatology (Neuromodulators, fillers)]; Galderma; L'Oreal [Skinboosters; skincare (Topical acne and rosacea treatments)]; L'Oreal; Merz; BonTi; Zeltiq [Skincare (Neuromodulator, cryolipolysis)]."},{"name":"Raegan Hunt, MD, PhD","credentials":["Assistant Professor of Dermatology and Pediatrics\n","Texas Children's Hospital\n","Baylor College of Medicine"],"disclosure":""},{"name":"Sameera Husain, MD","credentials":["Associate Professor of Dermatology in Pathology\n","Columbia University Medical Center"],"disclosure":""},{"name":"Clare Hutchinson, MDCM, FRCPC","credentials":["Pediatric Rheumatologist\n","University of Toronto"],"disclosure":""},{"name":"John R Ingram, MD, PhD","credentials":["Senior Lecturer and Consultant Dermatologist\n","Division of Infection and Immunity\n","Cardiff University, Cardiff, United Kingdom"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Hidradenitis suppurativa (Adalimumab)]. Speaker's Bureau: AbbVie [Hidradenitis suppurativa (Adalimumab)]; UCB Pharm [Hidradenitis suppurativa]. Other Financial Interest: British Journal of Dermatology [Editorial stipend]."},{"name":"Stuart N Isaacs, MD","credentials":["Associate Professor\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":""},{"name":"Geoffrey K Isbister, MD","credentials":["Professor, Clinical Toxicology Research Group\n","University of Newcastle, Australia"],"disclosure":""},{"name":"Peter Itin, MD","credentials":["Head of Department of Dermatology\n","University of Basel"],"disclosure":""},{"name":"Jeremy D Jackson, MD","credentials":["Associate Professor of Dermatology\n","University of Mississippi Medical Center"],"disclosure":""},{"name":"Heidi Jacobe, MD","credentials":["Associate Professor of Dermatology\n","University of Texas Southwestern"],"disclosure":""},{"name":"Eric Jacobsen, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene [Histiocytoses (Lenalidomide)]. Consultant/Advisory Boards: Seattle Genetics [T cell lymphoma (Brentuximab)]; Spectrum [T cell lymphoma (Pralatrexate, romidepsin)]; Merck (Temsirolimus); Pharmacyclics (Ibrutinib)."},{"name":"Jared Jagdeo, MD, MS","credentials":["Associate Professor of Dermatology\n","University of California, Davis"],"disclosure":""},{"name":"Natalia Jaimes, MD","credentials":["Assistant Professor\n","Miller School of Medicine, University of Miami"],"disclosure":""},{"name":"Natasha R Johnson, MD","credentials":["Assistant Professor in Obstetrics, Gynecology and Reproductive Biology\n","Harvard Medical School"],"disclosure":""},{"name":"Joseph Jorizzo, MD","credentials":["Professor and Former (Founding) Chair\n","Wake Forest University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Psoriasis]."},{"name":"Marshall E Kadin, MD","credentials":["Professor of Dermatology\n","Boston University School of Medicine"],"disclosure":""},{"name":"Robert E Kalb, MD","credentials":["Clinical Professor of Dermatology\n","State University of New York at Buffalo"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Psoriasis (Adalimumab)]; Amgen [Psoriasis (Etanercept)]; Boehringer Ingelheim [Psoriasis]; Janssen [Psoriasis (Ustekinumab)]; LEO Pharma [Psoriasis (Taclonex)]; Merck [Psoriasis]; Novartis [Psoriasis (Secukinumab)].Consultant/Advisory Boards: AbbVie [Psoriasis (Adalimumab)]; Dermira [Psoriasis (Certolizumab)] Janssen [Psoriasis (Ustekinumab)]; Eli Lilly [Psoriasis (Ixekizumab)]; Sun Pharmaceuticals [Psoriasis (Tildrakizumab)]."},{"name":"Sewon Kang, MD","credentials":["Noxell Professor & Chair, Department of Dermatology\n","Johns Hopkins School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Unilever [Skin aging]; L'Oreal [Skin aging]. Consultant/Advisory Boards: Unilever [Skin barrier]; L'Oreal [Skin aging]. Patent Holder: Co-inventor [Skin aging, patent owned by University of Michigan]."},{"name":"Souha S Kanj, MD","credentials":["Professor of Medicine\n","Head, Division of Infectious Diseases,\n","Chairperson, Infection Control Program\n","American University of Beirut Medical Center"],"disclosure":"Speaker's Bureau: Merck [Antibiotics (Ceftolozane/tazobactam)]. Consultant/Advisory Boards: Merck [Antibiotics (Ceftolozane/tazobactam)]."},{"name":"Pritesh S Karia, MPH","credentials":["Manager - Dermatologic Oncology Research Program\n","Brigham and Women's Hospital"],"disclosure":""},{"name":"Andreas Katsambas, MD","credentials":["Professor of Dermatology\n","University of Athens"],"disclosure":""},{"name":"Stephen Kells, PhD","credentials":["Associate Professor of Entomology\n","University of Minnesota"],"disclosure":""},{"name":"Kristen M Kelly, MD","credentials":["Professor of Dermatology and Surgery \n","University of California Irvine"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan [Rosacea (Oxymetazoline hydrochloride cream)]; Novartis [Breast, kidney, lung, and pancreatic cancer (Everolimus)]; Syneron-Candela [Vascular lesions, rosacea, pigmented lesions (Pulsed dye laser)]; ThermiGen [Cosmetic therapy (Temperature-controlled radiofrequency devices)]. Consultant/Advisory Boards: Allergan [Rosacea (Oxymetazoline hydrochloride cream)]; Syneron-Candela [Vascular lesions, rosacea, pigmented lesions (Pulsed dye laser)]."},{"name":"Robert Kelly, MD","credentials":["Head of Clinical Dermatology, Department of Dermatology\n","St Vincent’s Hospital / Melbourne University"],"disclosure":""},{"name":"David A Khan, MD","credentials":["Professor of Medicine and Pediatrics\n","UT Southwestern Medical Center"],"disclosure":"Speaker's Bureau: Genentech [Urticaria (Omalizumab)]. Consultant/Advisory Boards: Aimmune [Food allergy]."},{"name":"Nonhlanhla P Khumalo, MBChB, FCDerm, PhD","credentials":["Professor, Head of Dermatology\n","Groote Schuur Hospital and The University of Cape Town"],"disclosure":""},{"name":"Abdul-Ghani Kibbi, MD, FACP, FAAD","credentials":["Professor and Chair, Department of Dermatology\n","American University of Beirut Medical Center"],"disclosure":""},{"name":"Ellen J Kim, MD","credentials":["Associate Professor of Dermatology\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Kyowa Hakko Kirin [CTCL clinical trial investigator (anti-CCR4 [KW0761, mogamulizumab])]; Solgenix [CTCL clinical trial investigator (hypericin photodynamic topical agent)]; Actelion [CTCL clinical trial investigator (nitrogen mustard gel)]. Consultant/Advisory Boards: Actelion [CTCL (nitrogen mustard gel)]."},{"name":"Gene Kim, MD","credentials":["Assistant Professor of Pathology and Dermatology\n","University of Southern California"],"disclosure":""},{"name":"Jinah Kim, MD","credentials":["Assistant Professor of Dermatology\n","Stanford University"],"disclosure":""},{"name":"Susan Kim, MD, MMSc","credentials":["Associate Professor of Pediatrics\n","University of California, San Francisco"],"disclosure":""},{"name":"Youn H Kim, MD","credentials":["Professor of Dermatology\n","Stanford University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Esai [CTCL (E7777/denileukin diftitox)], Kyowa Hakko Kirin [CTCL (mogamulizumab)], Merck [CTCL (Pembromulizumab)], Millennium/Takeda [CTCL (brentuximab vedotin)], Seattle Genetics [CTCL (brentuximab vedotin)], Soligenix [CTCL (TOPICAL SGX301)], Tetralogic [CTCL (SHAPE)], Neumedicine [CTCL (Interleukin-12)], Innate [CTCL (IPH4102)], Infinity Pharmaceuticals. Consultant/Advisory Boards: Actelion [CTCL], Celgene [CTCL (Romidepsin)], Eisai [CTCL (E7777/denileukin diftitox)], Galderma [CTCL], Kyowa Hakko Kirin [CTCL (Mogamulizumab)], Millennium/Takeda Pharma [CTCL (Brentuximab Vedotin)], Seattle Genetics [CTCL (Brentuximab Vedotin)], Forty Seven Inc [CTCL], Horizon Pharma [CTCL (Actimmune)], Portola Pharma [CTCL (Cerdulatinib)], miRagen [CTCL (AntimiR-155 MRG-106)], Medivir."},{"name":"Talmadge E King, Jr, MD","credentials":["Editor-in-Chief — Pulmonary and Critical Care Medicine\n","Section Editor — Interstitial Lung Disease\n","Dean, School of Medicine \n","Vice Chancellor, Medical Affairs\n","University of California San Francisco"],"disclosure":""},{"name":"Robyn S Klein, MD, PhD","credentials":["Associate Professor of Medicine\n","Washington University School of Medicine"],"disclosure":""},{"name":"Hiroshi Koga, MD","credentials":["Assistant Professor of Dermatology\n","Shinshu University School of Medicine"],"disclosure":""},{"name":"Michihiro Kono, MD, PhD","credentials":["Associate Professor, Department of Dermatology\n","Nagoya University Graduate School of Medicine"],"disclosure":""},{"name":"John Koo, MD","credentials":["Professor of Clinical Dermatology\n","University of California San Francisco"],"disclosure":""},{"name":"Neil Korman, MD, PhD","credentials":["Professor of Dermatology\n","Case Western Reserve University"],"disclosure":""},{"name":"Arianne Shadi Kourosh, MD","credentials":["Director of Community Health\n","Department of Dermatology, Massachusetts General Hospital and Harvard Medical School"],"disclosure":""},{"name":"Alexander Kreuter, MD","credentials":["Head of the Department of Dermatology\n","HELIOS St. Elisabeth Hospital"],"disclosure":"Consultant/Advisory Boards: Sanofi Pasteur [Human papillomavirus (Human papillomavirus 9-valent vaccine)]; Merck Sharp & Dohme Corp. [Human papillomavirus (Human papillomavirus 9-valent vaccine)]; Novartis International AG [Psoriasis (Secukinumab)]; AbbVie [Hidradenitis suppurativa (Adalimumab)]. Other Financial Interest: Actelion Pharmaceuticals, Ltd. [Systemic sclerosis (Bosentan)]."},{"name":"Daniela Kroshinsky, MD","credentials":["Assistant Professor of Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Jean Krutmann, MD","credentials":["Professor of Dermatology & Environmental Medicine, Director \n","IUF – Leibniz-Institut für umweltmedizinische Forschung an der Heinrich-Heine-University Duesseldorf, Germany"],"disclosure":""},{"name":"Roopal Kundu, MD","credentials":["Associate Professor of Dermatology and Medical Education\n","Northwestern University, Feinberg School of Medicine"],"disclosure":""},{"name":"Kelly KyungHwa Park, MD","credentials":["Mohs Micrographic Surgery and Dermatologic Oncology Fellow\n","Skin Institute of South Florida"],"disclosure":""},{"name":"Mario E Lacouture, MD","credentials":["Associate Professor of Medicine \n","Cornell University\n","Member\n","Memorial Hospital\n","Memorial Sloan Kettering Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Berg [Rash (Calcitriol)]; Bristol-Myers Squibb [Rash (Cetuximab)]. Consultant/Advisory Boards: Quintiles [Rash (Anti-epidermal growth factor receptor monoclonal antibody mixture)]; Boehringer Ingelheim [Rash (Afatinib)]; AstraZeneca [Rash (Osimertinib)]; Foamix Pharmaceuticals [Rash (Doxycycline)]; Novartis [Rash (Alpelisib)]; Novocure [Rash (Device used to treat glioblastoma multiforme)]."},{"name":"Martin Laimer, MD","credentials":["Associate Professor of Dermatology and Venereology \n","Paracelsus Medical University Salzburg"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen; Bristol-Myers Squibb [Melanoma (Talimogene laherparepvec, pembrolizumab, ipilimumab, nivolumab)]."},{"name":"Tahaniyat Lalani, MBBS, MHS","credentials":["Associate Professor\n","Uniformed Services University of the Health Sciences"],"disclosure":""},{"name":"Megan N Landis, MD","credentials":["Assistant Clinical Professor of Dermatology\n","University of Louisville School of Medicine"],"disclosure":""},{"name":"Fiona Larsen, MBChB, FRACP","credentials":["Dermatologist"],"disclosure":""},{"name":"Marc R Laufer, MD","credentials":["Professor of Obstetrics, Gynecology, and Reproductive Biology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: AbbVie [Endometriosis (Elagolix)]; Nextjane Gen [Endometriosis (test)]."},{"name":"Leslie P Lawley, MD","credentials":["Assistant Professor of Dermatology\n","Emory University School of Medicine"],"disclosure":""},{"name":"Ronald Laxer, MD, FRCPC","credentials":["Professor of Pediatrics\n","University of Toronto"],"disclosure":"Grant/Research/Clinical Trial Support: Scleroderma Society of Ontario [Morphea (Studies)]."},{"name":"Erica Lee, MD","credentials":["Instructor of Dermatology\n","Weill Cornell Medical College"],"disclosure":""},{"name":"Lela Lee, MD","credentials":["Clinical Professor of Dermatology\n","University of Colorado School of Medicine"],"disclosure":""},{"name":"Kristin M Leiferman, MD","credentials":["Professor of Dermatology\n","University of Utah"],"disclosure":"Employment: University of Utah Department of Dermatology, Co-Director Immunodermatology Laboratory [Pemphigoid (Immunoassays performed for the diagnosis of immunobullous diseases)]."},{"name":"Alexander KC Leung, MBBS, FRCPC, FRCP (UK & Ireland), FRCPCH, FAAP","credentials":["Clinical Professor of Pediatrics\n","University of Calgary"],"disclosure":""},{"name":"Moise L Levy, MD","credentials":["Section Editor — Pediatric Dermatology\n","Professor of Pediatrics and Medicine (Dermatology)\n","Dell Medical School, University of Texas, Austin\n","Clinical Professor of Dermatology and Pediatrics\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Anacor Pharmaceuticals [Atopic dermatitis (Investigational drug)]; Scioderm [Epidermolysis bullosa (Topical treatment investigation)]. Speaker's Bureau: Anacor Pharmaceuticals [Atopic dermatitis (Investigational drug)]. Consultant/Advisory Boards: Castle Creek Pharmaceuticals [Epidermolysis bullosa (New drug in development)]. Patent Holder: Incontinentia pigmenti (NEMO gene mutations)."},{"name":"Jean Lee Lim, MD","credentials":["Department of Dermatology\n","Kaiser Permanente Medical Group, Santa Rosa, CA"],"disclosure":""},{"name":"Marilyn Ling, MD","credentials":["Associate Professor\n","Department of Radiation Oncology\n","University of Rochester Medical Center"],"disclosure":""},{"name":"Peter A Lio, MD","credentials":["Clinical Assistant Professor of Dermatology and Pediatrics\n","Northwestern University Feinberg School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AOBiome [Atopic dermatitis (Topical probiotic spray)]. Speaker's Bureau: Regeneron Pharmaceuticals [Atopic dermatitis (Dupilumab)]; Pfizer [Atopic dermatitis (Crisaborole)]. Consultant/Advisory Boards: Sanofi [Atopic dermatitis (Dupilumab)]; Pfizer [Atopic dermatitis (Crisaborole)]; Realm Therapeutics [Atopic dermatitis (Future medication)]."},{"name":"Dan Lipsker, MD, PhD","credentials":["Medical Faculty\n","University of Strasbourg"],"disclosure":""},{"name":"Vincent Liu, MD","credentials":["Clinical Professor\n","Departments of Dermatology and Pathology\n","University of Iowa Carver College of Medicine"],"disclosure":""},{"name":"Fred A Lopez, MD","credentials":["Richard Vial Professor and Vice Chair\n","Louisiana State University School of Medicine"],"disclosure":""},{"name":"Emily Broun Lund, MD","credentials":["University of Chicago"],"disclosure":""},{"name":"David Mabey, BM, BCh, DM, FRCP","credentials":["Professor of Communicable Diseases\n","London School of Hygiene and Tropical Medicine"],"disclosure":""},{"name":"Maria Juliet E Macarayo, MD","credentials":["Consultant, Department of Dermatology\n","Angeles University Foundation Medical Center"],"disclosure":"Speaker's Bureau: Galderma Philippines [Acne, atopic dermatitis, eczema, rosacea (Adapalene and benzoyl peroxide, adapalene, skin cleanser, moisturizing cream, brimonidine, desonide)]; Menarini Group [Seborrheic dermatitis, atopic dermatitis, eczema, acne, urticaria (Acne prevention cream, acne prevention gel, acne prevention ointment, nonsteroidal cream for eczema, antihistamine, nonsteroidal cream for seborrheic dermatitis)]; LEO Pharma [Infectious diseases, psoriasis (Fusidic acid, psoriasis gel and cream)]; Brady Pharma [Pigmentary disorders (Pigmentation removal products)]; Glenmark Philippines [Atopic dermatitis, psoriasis, eczema, acne (Halobetasol, adapalene, tacrolimus)]. Consultant/Advisory Boards: Acne Board of the Philippines [Acne (Acne products and dermocosmetics)]."},{"name":"Jennifer L MacGregor, MD","credentials":["Clinical Professor of Dermatology\n","Columbia University Medical Center, New York"],"disclosure":"Consultant/Advisory Boards: Allergan [Rosacea (oxymetazoline hydrochloride cream 1%)]."},{"name":"Julian M Mackay-Wiggan, MD, MS","credentials":["Associate Professor of Dermatology\n","Columbia University Medical Center"],"disclosure":""},{"name":"Ian A Maher, MD","credentials":["Assistant Professor\n","Department of Dermatology, Saint Louis University"],"disclosure":""},{"name":"Mary Maiberger, MD","credentials":["Associate Professor of Dermatology\n","Howard University\n","Associate Clinical Professor of Dermatology"],"disclosure":""},{"name":"Lisa E Maier, MD","credentials":["Clinical Associate Professor, Department of Dermatology\n","University of Washington\n","Adjunct, Department of Dermatology\n","University of Michigan"],"disclosure":""},{"name":"Mary E Maloney, MD","credentials":["Professor of Medicine (Dermatology)\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Erin N Marcus, MD, MPH, FACP","credentials":["Associate Professor of Clinical Medicine\n","University of Miami Miller School of Medicine"],"disclosure":""},{"name":"Ashfaq A Marghoob, MD","credentials":["Attending Physician\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"James G Marks, Jr, MD","credentials":["Professor and Chair, Department of Dermatology\n","Penn State Milton S. Hershey Medical Center"],"disclosure":""},{"name":"Jose Dario Martinez Villarreal, MD","credentials":["Professor of Internal Medicine and Dermatology\n","University Hospital, Universidad Autonoma de Nuevo Leon, School of Medicine"],"disclosure":""},{"name":"Renato G Martins, MD, MPH","credentials":["Medical Director\n","Professor\n","University of Washington\n","Seattle Cancer Care Alliance"],"disclosure":""},{"name":"Cesare Massone, MD","credentials":["Medical Director, Dermatology Unit\n","Galliera Hospital, Genova, Italy\n","Associate Professor, Department of Dermatology\n","Medical University of Graz, Graz, Austria"],"disclosure":""},{"name":"Barbara M Mathes, MD, FACP, FAAD","credentials":["Clinical Associate, Dermatology\n","University of Pennsylvania\n","Secretary Treasurer\n","American Academy of Dermatology"],"disclosure":""},{"name":"Erin Mathes, MD","credentials":["Associate Professor of Dermatology\n","Departments of Dermatology and Pediatrics\n","University of California, San Francisco"],"disclosure":"Consultant/Advisory Boards: Zosano Pharma [Migraine (Drug delivery device)]; Rodan & Fields (Cosmetics); Laboratoires Pierre Fabre [Hemangioma (Propranolol hydrochloride)]."},{"name":"Marcus Maurer, MD","credentials":["Professor of Dermatology and Allergy\n","Charité – Universitätsmedizin Berlin, Germany"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Urticaria (Omalizumab)]; Genentech [Urticaria (Omalizumab)]; Uriach [Urticaria (Rupatadine)]; Abbott Laboratories [Urticaria (Rupatadine)]; FAES [Urticaria (Bilastine)]; UCB [Urticaria (Levocetirizine)]; Moxie [Urticaria (TempTest)]. Consultant/Advisory Boards: Novartis [Urticaria (Omalizumab)]; Genentech [Urticaria (Omalizumab)]; Uriach [Urticaria (Rupatadine)]; Abbott Laboratories [Urticaria (Rupatadine)]; FAES [Urticaria (Bilastine)]; MSD [Urticaria (Desloratadine)]; Almirall [Urticaria (Ebastine)]; UCB [Urticaria (Levocetirizine)]; Moxie [Urticaria (TempTest)]; Sanofi [Urticaria (Fexofenadine)]."},{"name":"Toby Maurer, MD","credentials":["Professor of Dermatology\n","University of California, San Francisco, School of Medicine"],"disclosure":""},{"name":"Edward V Maytin, MD, PhD","credentials":["Staff\n","Department of Dermatology, Cleveland Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Sun Pharmaceuticals Industries [Photodynamic therapy (5-aminolevulinate)]. Consultant/Advisory Boards: Sun Pharmaceuticals Industries [Photodynamic therapy (5-aminolevulinate)]."},{"name":"Timothy H McCalmont, MD","credentials":["Professor of Dermatology and Pathology\n","University of California, San Francisco"],"disclosure":""},{"name":"Kenneth L McClain, MD, PhD","credentials":["Professor of Pediatrics\n","Texas Children's Cancer Center/Hematology Service\n","Baylor College of Medicine"],"disclosure":""},{"name":"Catherine McCuaig, MD","credentials":["Associate Clinical Professor of Dermatology\n","University of Montreal"],"disclosure":"Consultant/Advisory Boards: Johnson & Johnson [Aging, sun protection (Water gel, broad spectrum sunscreen)]; Janssen Pharmaceutica [Psoriasis (Infliximab)]; AbbVie [Psoriasis (Adalimumab)]; Novartis [Urticaria, psoriasis (Omalizumab, secukinumab)]."},{"name":"Laura Y McGirt, MD","credentials":["Director of Dermatologic Oncology\n","Levine Cancer Institute at Carolina's Medical Center, Charlotte, North Carolina"],"disclosure":"Consultant/Advisory Boards: Actelion [Parapsoriasis (Mechlorethamine)]; Mallinckrodt Pharmaceuticals [Parapsoriasis (Extracorporeal photopheresis)]."},{"name":"Thomas McGovern, MD","credentials":["Private Practice\n","Fort Wayne, IN"],"disclosure":""},{"name":"Beth N McLellan, MD","credentials":["Assistant Professor\n","Albert Einstein College of Medicine"],"disclosure":"Consultant/Advisory Boards: Ferndale Pharma Group [Radiation dermatitis (Polypodium leucotomos extract dietary supplement)]."},{"name":"Amy McMichael, MD","credentials":["Professor of Dermatology\n","Wake Forest University Baptist Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan [Hair loss (Bimatoprost)]; Cassiopea [Hair loss]; Proctor & Gamble [Hair loss (Age defy hair product)]; Samumed [Hair loss]. Consultant: Aclaris; Cassiopea; eResearch Technology; Covance; Galderma; Guthey Renker; Incyte; Keranetics; Merz Pharmaceuticals; Samumed [Hair loss]; Allergan [Hair loss (Bimatoprost)]; Johnson & Johnson [Hair loss (Rogaine)]; Merck [Hair loss (Propecia)]; Proctor & Gamble [Hair loss (Age defy hair product)]. Royalties: Informa Healthcare [Hair loss]."},{"name":"Stephanie Mehlis, MD","credentials":["Clinical Instructor, Division of Dermatology \n","University of Chicago, Pritzker School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Plaque psoriasis (Secukinumab)]; Janssen Pharmaceutica [Plaque psoriasis (Guselkumab)]; Boehringer Ingelheim Pharmaceuticals, Inc. [Plaque psoriasis (Risankizumab)]; Eli Lilly and Company [Plaque psoriasis (Ixekizumab)]. Speaker's Bureau: Novartis [Psoriasis (Secukinumab)]. Consultant/Advisory Boards: Janssen Pharmaceutica [Psoriasis (Ustekinumab and infliximab)]; Novartis [Psoriasis (Secukinumab)]. Equity Ownership/Stock Options (Spouse): AbbVie Inc. [Plaque psoriasis (Adalimumab)]; Johnson & Johnson [Psoriasis (Ustekinumab and infliximab)]; Novartis [Psoriasis (Secukinumab)]."},{"name":"Joseph F Merola, MD, MMSc, FAAD, FACR","credentials":["Assistant Professor, Harvard Medical School\n","Department of Dermatology\n","Department of Medicine, Division of Rheumatology \n","Brigham and Women's Hospital"],"disclosure":"Grant/Research Support: Biogen [Cutaneous lupus erythematosus]; Pfizer [Psoriatic arthritis (Tofacitinib)]; Boehringer Ingelheim Pharmaceuticals [Psoriasis (Ustekinumab)]; Eli Lily and Company [Psoriasis (Ixekizumab)]. Speakers Bureau: AbbVie [Psoriasis (Adalimumab)]. Consultant/Advisory Boards: Biogen [Cutaneous lupus erythematosus]; AbbVie [Psoriasis, psoriatic arthritis (Adalimumab)]; Amgen [Psoriasis, psoriatic arthritis (Etanercept)]; Eli Lilly and Company [Psoriasis, psoriatic arthritis (Tofacitinib)]; Novartis [Psoriasis, psoriatic arthritis (Secukinumab)]; Pfizer [Psoriasis, psoriatic arthritis (Tofacitinib)]; Janssen Pharmaceutica [Psoriasis, psoriatic arthritis (Ustekinumab)]; Momenta Pharmaceuticals [Connective tissue disease]; Mallinckrodt Pharmaceuticals [Psoriasis, psoriatic arthritis (Repository corticotropin injection)]. Patent Holder: AbbVie [Psoriasis (Licensed outcome measure)]."},{"name":"Andrew G Messenger, MD, FRCP","credentials":["Professor of Dermatology\n","University of Sheffield"],"disclosure":""},{"name":"Andrei Metelitsa, MD, FRCPC","credentials":["Clinical Assistant Professor, Division of Dermatology\n","University of Calgary"],"disclosure":""},{"name":"Denise W Metry, MD","credentials":["Associate Professor of Dermatology and Pediatrics\n","Baylor College of Medicine"],"disclosure":""},{"name":"Robert G Micheletti, MD","credentials":["Assistant Professor of Dermatology and Medicine\n","University of Pennsylvania\n","Perelman School of Medicine"],"disclosure":""},{"name":"Barbara Miedzybrodzki, MD","credentials":["Postgraduate Training-Fellow in Pediatric Dermatology\n","Ste-Justine Hospital, University of Montreal"],"disclosure":""},{"name":"Martin C Mihm, Jr, MD","credentials":["Clinical Professor of Pathology\n","Harvard Medical School\n","Brigham and Women's Hospital"],"disclosure":"Consultant/Advisory Boards: Novartis [Multiple tumor therapies]; Alnylam [Question of allergic reaction to injected microRNA conjugates]; MelaSciences [Clinical diagnosis in melanoma]; Caliber I.D. [Confocal microscope diagnosis of tumors (Pre- and postbiopsy drugs)]; Biocoz [Skin activation and wound recovery (Cutaneous lotion/moisturizer)]. Other Financial Interest: John Wiley & Sons [Published book]."},{"name":"Daniel D Miller, MD","credentials":["Assistant Professor\n","University of Minnesota Department of Dermatology"],"disclosure":""},{"name":"Jami L Miller, MD","credentials":["Assistant Professor of Medicine\n","Vanderbilt University"],"disclosure":""},{"name":"Marc L Miller, MD","credentials":["Clinical Assistant Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Paradi Mirmirani, MD","credentials":["Department of Dermatology\n","The Permanente Medical Group, Vallejo CA"],"disclosure":""},{"name":"Ginat W Mirowski, DMD, MD","credentials":["Associate Professor\n","Department of Oral Pathology, Medicine, and Radiology - Indiana University, School of Dentistry"],"disclosure":""},{"name":"Dana Miskulin, MD","credentials":["Associate Professor\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Oriol Mitjà, MD, PhD, DTMH","credentials":["Assistant Research Professor\n","Barcelona Institute for Global Health, University of Barcelona"],"disclosure":""},{"name":"Sahil Mittal, MD, MS","credentials":["Assistant Professor\n","Baylor College of Medicine"],"disclosure":""},{"name":"Kimberly Morishita, MD, MHSc, FRCPC","credentials":["Clinical Assistant Professor of Pediatrics\n","Division of Rheumatology, Department of Pediatrics\n","University of British Columbia"],"disclosure":""},{"name":"Akimichi Morita, MD, PhD","credentials":["Professor and Chairman, Department of Geriatric and Environmental Dermatology\n","Nagoya City University Graduate School of Medical Sciences"],"disclosure":""},{"name":"Dean Morrell, MD","credentials":["Associate Professor, Department of Dermatology\n","University of North Carolina Chapel Hill"],"disclosure":""},{"name":"Rachael Morris-Jones, FRCP, PhD, PCME","credentials":["Dermatology Consultant and Associate Clinical Dean\n","King's College Hospital and King's College London"],"disclosure":""},{"name":"Samuel L Moschella, MD, FAAD, FACP","credentials":["Lahey Clinic"],"disclosure":""},{"name":"Eliot Mostow, MD","credentials":["Professor and Chair, Dermatology Section\n","Northeastern Ohio University College of Medicine"],"disclosure":"Consultant/Advisory Boards: Vivacare [Patient information on web and app platforms]. Employment: Elsevier [Dermatology Assistant Editor, practiceupdate.com]."},{"name":"Kiran Motaparthi, MD","credentials":["Assistant Professor\n","Department of Dermatology\n","University of Florida College of Medicine"],"disclosure":""},{"name":"Christen Mowad, MD","credentials":["Clinical Professor\n","Temple University"],"disclosure":"Consultant/Advisory Boards: PracticeUpdate."},{"name":"John C Murray, MD","credentials":["Professor of Medicine (Dermatology)\n","Duke University Medical Center"],"disclosure":""},{"name":"Dedee F Murrell, MD","credentials":["Professor and Chair of Dermatology, St. George Hospital\n","University of New South Wales, Sydney, Australia"],"disclosure":"Grant/Research/Clinical Trial Support: Scioderm/Amicus Therapeutics [Epidermolysis bullosa (Allantoin)]; Castle Creek Pharmaceuticals LLC [Epidermolysis bullosa simplex (Topical diacerein)]; Amryt Pharma [Epidermolysis bullosa (Oleogel)]; Principia Biopharma [Pemphigus, bullous pemphigoid (Bruton's tyrosine kinase inhibitor)]; Roche [Pemphigus, bullous pemphigoid (Rituximab)]. Consultant/Advisory Boards: Roche; Principia Biopharma; Immune Pharma; GSK [Pemphigus, bullous pemphigoid (Rituximab, Bruton's tyrosine kinase inhibitor, bertilimumab, ofatumumab)]."},{"name":"Amy Musiek, MD","credentials":["Assistant Professor of Medicine\n","Washington University, St. Louis"],"disclosure":"Speaker's Bureau: Actelion [Cutaneous T cell lymphoma (Nitrogen mustard, mechlorethamine)]. Consultant/Advisory boards: Actelion [Cutaneous T cell lymphoma (Nitrogen mustard, mechlorethamine)]; Kyowa Hakko Kirin [Cutaneous T cell lymphoma (Mogamulizumab)]; Seattle Genetics [Hodgkin lymphoma, anaplastic large cell lymphoma (Brentuximab vedotin)]."},{"name":"Kishwer Nehal, MD","credentials":["Associate Professor of Dermatology\n","Cornell Weill Medical College"],"disclosure":""},{"name":"Megan H Noe, MD, MPH","credentials":["Clinical Instructor and Postdoctoral Research Fellow\n","University of Pennsylvania Department of Dermatology"],"disclosure":""},{"name":"Jeffrey P North, MD","credentials":["Assistant Professor of Dermatology and Pathology\n","University of California, San Francisco"],"disclosure":""},{"name":"Julia R Nunley, MD","credentials":["Professor, Dermatology\n","Virginia Commonwealth University School of Medicine"],"disclosure":""},{"name":"Abena O Ofori, MD","credentials":["Deputy Editor — Dermatology\n","Assistant Professor of Medicine, Dermatology Division\n","Medical College of Georgia"],"disclosure":""},{"name":"Sang Ho Oh, MD, PhD","credentials":["Associate Professor\n","Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea"],"disclosure":""},{"name":"Suzanne Olbricht, MD","credentials":["Associate Professor of Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Dennis P Orgill, MD, PhD","credentials":["Professor of Surgery\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Acelity [Wound healing (VAC devices)]; Integra LifeSciences [Wound healing (Dermal regeneration template)]; Musculoskeletal Research Foundation (Wound healing products). Consultant/Advisory Boards: Acelity [Wound healing (VAC devices)]; Integra LifeSciences [Wound healing (Dermal regeneration template)]; Musculoskeletal Research Foundation (Wound healing products). Equity Ownership/Stock Options: HyperMed (Perfusion monitoring systems)."},{"name":"Cindy Owen, MD","credentials":["Assistant Professor of Medicine\n","University of Louisville"],"disclosure":""},{"name":"R Steven Padilla, MD","credentials":["Professor of Dermatology & Pathology\n","The University of New Mexico School of Medicine"],"disclosure":"Consultant/Advisory Boards: Athenex [Actinic keratosis (Experimental ointment)]."},{"name":"Debra L Palazzi, MD, MEd","credentials":["Associate Professor of Pediatrics, Infectious Diseases Section\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Invasive fungal infections (Caspofungin, posaconazole)]; Durata [Antibiotic safety and PK (Dalbavancin)]; Cempra [Antibiotic safety and PK (Solithromycin)]. Consultant/Advisory Boards: Pfizer [Antifungal trial data safety monitoring board (Voriconazole, Anidulafungin)]. Other Financial Interest: JAMA Peds Associate Editor [pediatrics (journal articles)]; AAP PREP ID Editorial board [PREP ID educational products and course]."},{"name":"Amy S Paller, MD","credentials":["Walter J. Hamlin Professor and Chair of Dermatology\n","Professor of Pediatrics\n","Director, Northwestern University Skin Disease Research Center\n","Northwestern University Feinberg School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Psoriasis (Adalimumab)]; Celgene Corporation [Psoriasis (Apremilast)]; Eli Lilly and Company [Psoriasis (Ixekizumab)]; Novartis [Psoriasis (Secukinumab)]. Consultant/Advisory Boards: Amgen [Psoriasis (Etanercept)]; Celgene [Psoriasis (Apremilast)]; Eli Lilly and Company [Psoriasis (Ixekizumab)]; Janssen Pharmaceutical [Psoriasis (Ustekinumab)]; Novartis [Psoriasis (Secukinumab)]; Stiefel Laboratories [Psoriasis (Calcipotriene)]."},{"name":"Alberto S Pappo, MD","credentials":["Section Editor — Pediatric Oncology\n","Head of Solid Malignancies Program\n","St. Jude Children's Research Hospital"],"disclosure":""},{"name":"Taraneh Paravar, MD","credentials":["Assistant Professor, Department of Dermatology\n","University of California, San Diego"],"disclosure":""},{"name":"David Pariser, MD","credentials":["Professor of Dermatology\n","Eastern Virginia Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Brickell Biotech [Hyperhidrosis]; Dermira [Hyperhidrosis]. Consultant/Advisory Boards: Brickell Biotech [Hyperhidrosis]; Dermira [Hyperhidrosis]."},{"name":"Eva R Parker, MD, FAAD","credentials":["Franklin Dermatology Group\n","Franklin, TN"],"disclosure":""},{"name":"Aimee S Payne, MD, PhD","credentials":["Associate Professor\n","Department of Dermatology\n","University of Pennsylvania"],"disclosure":""},{"name":"Marta J Petersen, MD","credentials":["Professor of Dermatology\n","University of Utah School of Medicine"],"disclosure":""},{"name":"Josie A Pielop, MD","credentials":["Memorial Dermatology \n","Houston, TX"],"disclosure":""},{"name":"Miriam Keltz Pomeranz, MD","credentials":["Associate Professor of Dermatology\n","New York University School of Medicine"],"disclosure":""},{"name":"Elena Pope, MD, MSc, FRCPC","credentials":["Professor of Pediatrics\n","University of Toronto"],"disclosure":""},{"name":"Lori Prok, MD","credentials":["Assistant Professor of Dermatology and Pediatrics\n","University of Colorado Denver School of Medicine"],"disclosure":""},{"name":"Steven Prystowsky, MD","credentials":["Associate Professor\n","Department of Dermatology\n","New York University School of Medicine"],"disclosure":""},{"name":"Kate B Püttgen, MD, FAAD","credentials":["Assistant Professor of Dermatology and Pediatrics\n","Johns Hopkins University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Pierre-Fabre [Infantile hemangioma (propranolol)]."},{"name":"Flavio Queiroz-Telles, MD, PhD","credentials":["Associate Professor\n","Department of Public Health, Hospital de Clinicas\n","Federal University of Parana, Curitiba, Brazil"],"disclosure":""},{"name":"Elizabeth Quigley, MD","credentials":["Assistant Professor of Dermatology\n","Weill Medical College of Cornell University"],"disclosure":""},{"name":"Leslie Raffini, MD","credentials":["Associate Professor of Pediatrics\n","University of Pennsylvania"],"disclosure":""},{"name":"Priya Rajendran, MD","credentials":["Clinical Instructor\n","University of California, San Francisco"],"disclosure":""},{"name":"Mae Ramirez-Quizon, MD","credentials":["Consultant\n","St. Luke's Medical Center, Global City, Philippines"],"disclosure":""},{"name":"Caroline L Rao, MD","credentials":["Associate Professor\n","Duke Department of Dermatology"],"disclosure":""},{"name":"Jason Reichenberg, MD","credentials":["University of Texas Southwestern-Austin Program"],"disclosure":""},{"name":"Anetta Reszko, MD","credentials":["Assistant Professor of Dermatology\n","Weill Cornell Medical Center"],"disclosure":""},{"name":"Phoebe Rich, MD","credentials":["Clinical Associate Professor of Dermatology\n","Oregon Health Science University"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie [Psoriasis (Biologic)]; Allergan [Rosacea (Topical)]; Amgen [Psoriasis (Biologic)]; Dusa [Actinic (Topical)]; Eli Lilly [Keratosis (Biologic)]; Galderma [Psoriasis (Topical)]; Janssen [AV, atopic (Biologic)]; Merck & Co [Psoriasis (Biologic)]; Novartis [Onychomycosis (Biologic)]; Pfizer [Actinic (Topical)]; Valeant [Psoriasis (Topical)]; Viamet [AKs, tinea (Systemic)].\r\nConsultant/Advisory Boards: Novartis [Psoriasis (Biologic)]; Allergan [Acne (Systemic)]."},{"name":"Elisabeth G Richard, MD","credentials":["Assistant Professor of Dermatology\n","Johns Hopkins University"],"disclosure":""},{"name":"Helge Riemann, MD","credentials":["Mid Coast Dermatology, Brunswick, Maine"],"disclosure":""},{"name":"Simon A Ritchie, MD","credentials":["Assistant Professor of Dermatology\n","Uniformed Services University of the Health Sciences, Bethesda, MD"],"disclosure":""},{"name":"Mi Ryung Roh, MD, PhD","credentials":["Associate Professor\n","Department of Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research Institute\n","Yonsei University College of Medicine, Seoul, Korea"],"disclosure":""},{"name":"Thomas Rohrer, MD","credentials":["Clinical Associate Professor, Department of Dermatology\n","Brown University School of Medicine"],"disclosure":"Grant/Research Support: Merz Pharma [Toxins]. Speaker's Bureau: Candela/Syneron [Lasers (Pigmented lesion lasers)]. Consultant/Advisory Boards: Candela/Syneron [Lasers (Pigmented lesion lasers)]."},{"name":"Franco Rongioletti, MD","credentials":["Professor and Chairman\n","Unit of Dermatology\n","University of Cagliari, Italy"],"disclosure":""},{"name":"Alain H Rook, MD","credentials":["Professor of Dermatology\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Soligenix [CTCL research (hypericin clinical trial)]; Medimmune [CTCL trial]; Galderma [CTCL trial]."},{"name":"Misha Rosenbach, MD","credentials":["Assistant Professor of Dermatology and Internal Medicine\n","University of Pennsylvania Perelman School of Medicine"],"disclosure":"Consultant/Advisory Boards: Celgene [Sarcoidosis (Thalidomide, lenalidomide)]; Merck [Skin reactions, granulomatous reactions (PD1 inhibitor)]; Processa Pharmaceuticals [Necrobiosis lipoidica, granulomatous disease (Novel agent)]."},{"name":"Jean-Claude Roujeau, MD","credentials":["Section Editor — Drug Eruptions\n","Emeritus Professor of Dermatology\n","Université Paris-Est Créteil (UPEC), Créteil, France"],"disclosure":"Consultant/Advisory Boards: AB Science [Mastocytosis (Masitinib)]; SK Biopharmaceuticals [Epilepsy (YKP3089, a new AED in development)]."},{"name":"Beth S Ruben, MD","credentials":["Professor of Dermatology and Pathology\n","University of California, San Francisco"],"disclosure":""},{"name":"Michael R Rudnick, MD","credentials":["Associate Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Julie L Ryan Wolf, PhD, MPH","credentials":["Associate Professor, Departments of Dermatology and Radiation Oncology\n","University of Rochester Medical Center"],"disclosure":""},{"name":"Nazanin Saedi, MD","credentials":["Associate Professor of Dermatology and Cutaneous Biology\n","Thomas Jefferson University"],"disclosure":"Speaker's Bureau: Cynosure, Inc. [Lasers (Aesthetic picosecond laser)]; Solta Medical [Lasers (Aesthetic picosecond laser)]."},{"name":"Toshiaki Saida, MD, PhD","credentials":["Professor Emeritus\n","Shinshu University School of Medicine"],"disclosure":""},{"name":"Sarbjit Saini, MD","credentials":["Section Editor — Urticaria and Angioedema\n","Associate Professor of Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Asthma, urticaria (Omalizumab)]; AstraZeneca [Asthma, urticaria (Omalizumab)]. Consultant/Advisory Boards: Genentech [Urticaria (Omalizumab)]; Medimmune [Urticaria (Omalizumab)]."},{"name":"Andrew D Samel, MD","credentials":["Affiliate Staff Member\n","Sturdy Memorial Hospital"],"disclosure":""},{"name":"Liat Samuelov, MD","credentials":["Senior Physician, Department of Dermatology\n","Tel Aviv Sourasky Medical Center, Israel"],"disclosure":""},{"name":"Miguel Sanchez, MD","credentials":["Associate Professor\n","Department of Dermatology\n","New York University School of Medicine"],"disclosure":""},{"name":"Inbal Sander, MD","credentials":["Assistant Professor\n","Johns Hopkins University"],"disclosure":""},{"name":"Charles V Sanders, MD","credentials":["Edgar Hull Professor and Chair\n","Louisiana State University School of Medicine New Orleans"],"disclosure":"Equity Ownership/Stock Options: Baxter International, Inc."},{"name":"Denis Sasseville, MD, FRCPC","credentials":["Professor of Dermatology and Research Coordinator, Division of Dermatology\n","McGill University Health Centre"],"disclosure":""},{"name":"Diane MF Savarese, MD","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Oncology and Palliative Care\n","Clinical Instructor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Courtney Schadt, MD","credentials":["Assistant Professor\n","University of Louisville\n","Division of Dermatology"],"disclosure":""},{"name":"Julie V Schaffer, MD","credentials":["Attending in Pediatric Dermatology\n","Director, Pediatric Dermatology Fellowship\n","Division of Pediatric & Adolescent Dermatology \n","Hackensack University Medical Center"],"disclosure":""},{"name":"Peter C Schalock, MD","credentials":["Adjunct Associate Professor of Dermatology (Surgery)\n","Geisel School of Medicine, Dartmouth College"],"disclosure":""},{"name":"Noah Scheinfeld, MD","credentials":["Assistant Clinical Professor of Dermatology\n","Weill Cornell Medical College"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Hidradenitis suppurativa (Adalimumab)]. Consultant/Advisory Boards: AbbVie [Hidradenitis suppurativa (Adalimumab)]. Speaker’s Bureau: AbbVie [Hidradenitis suppurativa (Adalimumab)]."},{"name":"Pamela L Scheinman, MD","credentials":["Associate Professor of Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Bethanee J Schlosser, MD, PhD","credentials":["Associate Professor - Departments of Dermatology and Obstetrics/Gynecology\n","Northwestern University, Feinberg School of Medicine"],"disclosure":""},{"name":"Chrysalyne D Schmults, MD, MSCE","credentials":["Director of Mohs and Dermatologic Surgery and the High-Risk Skin Cancer Clinic\n","Brigham and Women's/Dana Farber Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Basal cell carcinoma (Vismodegib)]; Regeneron Pharmaceuticals [Cutaneous squamous cell carcinoma (Investigational programmed cell death-1 drug)]; Novartis [Basal cell carcinoma (Sonidegib)]. Consultant/Advisory Boards: Regeneron Pharmaceuticals [Nonmelanoma skin cancer (Investigational programmed cell death-1 drug)]."},{"name":"Sherry Scovell, MD, FACS","credentials":["Instructor in Surgery\n","Harvard Medical School/Massachusetts General Hospital"],"disclosure":""},{"name":"Emmanuel Seront, MD, PhD","credentials":["Department of Medical Oncology \n","Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Catholic University of Louvain, Brussels, Belgium"],"disclosure":""},{"name":"Daniel J Sexton, MD","credentials":["Editor-in-Chief — Infectious Diseases\n","Section Editor — Bacterial Infections\n","Professor of Medicine\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Centers for Disease Control and Prevention; National Institutes of Health [Healthcare epidemiology]. Consultant/Advisory Boards: Sterilis [Medical waste disposal]; Magnolia Medical Technologies [Medical diagnostics]; National Football League [Infection prevention]; Johnson & Johnson [Mesh-related infections]. Equity Ownership/Stock Options: Magnolia Medical Technologies [Medical diagnostics (Blood culture techniques)]. Other Financial Interest: Johnson & Johnson [Mesh-related infections]."},{"name":"Jerry Shapiro, MD","credentials":["Professor - The Ronald O. Perelman Department of Dermatology\n","New York University"],"disclosure":"Speaker's Bureau: Johnson and Johnson [Hair regrowth (Hair regrowth topical solution product)]."},{"name":"Michael P Sheehan, MD","credentials":["Volunteer Faculty\n","Indiana University School of Medicine\n","Department of Dermatology"],"disclosure":"Speaker's Bureau: Celgene [Psoriasis (Apremilast)]. Consultant/Advisory Boards: IntraDerm Pharmaceuticals [Contact dermatitis (HOCL gel)]."},{"name":"Donald W Shenenberger, MD, FAAD, FAAFP","credentials":["Assistant Professor of Dermatology\n","Eastern Virginia Medical School, Norfolk, VA"],"disclosure":""},{"name":"Tetsuo Shiohara, MD, PhD","credentials":["Professor and Chairman, Department of Dermatology \n","Kyorin University School of Medicine"],"disclosure":""},{"name":"Robert Sidbury, MD, MPH","credentials":["Professor - Department of Pediatrics\n","University of Washington School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Scioderm [Epidermolysis bullosa (Investigational cream)]; Sanofi/Regeneron [Atopic dermatitis (Investigational biologic)]. Consultant/Advisory Boards: Roche [Acne (Accutane - no longer made)]; Pfizer [Atopic dermatitis (Crisaborole)]."},{"name":"Dawn H Siegel, MD","credentials":["Associate Professor\n","Medical College of Wisconsin"],"disclosure":""},{"name":"Olga Simionescu, MD, PhD","credentials":["Professor and Head, 1st Clinic of Dermatology\n","Carol Davila University of Medicine and Pharmacy"],"disclosure":""},{"name":"Ashwani K Singal, MD, MS","credentials":["Associate Professor, Division of Gastroenterology and Hepatology\n","University of Alabama at Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: NIH, ACG [Porphyria, alcoholic liver disease]; Gilead Sciences, Aurora Pharmaceuticals [Alcoholic steatohepatitis, nonalcoholic steatohepatitis]; Alnylam Pharmaceuticals [Porphyria]. Consultant/Advisory Boards: Recordati [Porphyria (Hemin)]; Alnylam [siRNA for ALAS-1]; Gilead Sciences [Hepatitis B virus, Hepatitis C virus, nonalcoholic steatohepatitis]; Alexion Pharmaceuticals [Fatty liver disease]. Employment: UAB."},{"name":"Cassian Sitaru, MD","credentials":["Professor of Dermatology\n","University of Freiburg"],"disclosure":""},{"name":"C Christopher Smith, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Arthur J Sober, MD","credentials":["Professor of Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Denis Spelman, MBBS, FRACP, FRCPA, MPH","credentials":["Adjunct Professor, Monash University\n","Alfred Hospital, Victoria, Australia"],"disclosure":""},{"name":"Linda V Spencer, MD","credentials":["Spencer Dermatology Associates, LLC\n","Crawfordsville, Indiana"],"disclosure":""},{"name":"Jonathan M Spergel, MD, PhD, FAAAAI","credentials":["Professor of Pediatrics\n","University of Pennsylvania School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH; AImmune Therapeutics [Peanut allergy, eosinophilic esophagitis (Peanut powder)]. Consultant/Advisory Boards: Dannone; DBV [Food allergy (Milk and peanut patch)]. Equity Ownership/Stock Options: DBV Technology [Peanut allergy (Milk and peanut patch)]."},{"name":"Leonard C Sperling, MD","credentials":["Professor of Dermatology and Pathology\n","Uniformed Services University"],"disclosure":""},{"name":"Eli Sprecher, MD, PhD","credentials":["Chair and Professor, Department of Dermatology\n","Tel Aviv Sourasky Medical Center, Israel"],"disclosure":""},{"name":"Thomas Stasko, MD","credentials":["Professor and Chair - Department of Dermatology\n","The University of Oklahoma Health Sciences Center"],"disclosure":""},{"name":"Dennis L Stevens, MD, PhD","credentials":["Professor of Medicine\n","University of Washington School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Basic science (Tedizolid)]; Motif Bioscience [Basic science (Iclaprim)]."},{"name":"Michael Stone, MD","credentials":["Chairman of Surgery\n","Stamford Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Roche [Vasculitis (Tocilizumab)]; Genentech [IgG4-related disease (Rituximab)]; Xencor [IgG4-related disease (Xmab5871)]. Consultant/Advisory Boards: Roche [Vasculitis (Tocilizumab)]; Genentech [IgG4-related disease (Rituximab)]; Xencor [IgG4-related disease (Xmab5871)]."},{"name":"Bruce E Strober, MD, PhD","credentials":["Professor and Chair, Department of Dermatology\n","University of Connecticut Health Center"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie; Janssen [Psoriasis, hidradenitis suppurativa, atopic dermatitis]; Boehringer Ingelheim [Psoriasis (Interleukin-23 inhibitor)]; Celgene [Psoriasis (Apremilast)]; Novartis [Psoriasis (Secukinumab)]; Eli Lilly and Company [Psoriasis (Ixekizumab)]; Janssen [Psoriasis (Guselkumab)]; Merck/Sun [Psoriasis (Tildrakizumab)]; Sienna Biopharmaceuticals [Psoriasis (Future drug)]. Consultant/Advisory Boards: Sanofi-Regeneron [Atopic dermatitis (Dupilumab)]; LEO Pharma [Atopic dermatitis (Future drug)]; GlaxoSmithKline [Psoriasis (Future drug)]; AbbVie [Psoriasis (Adalimumab, risankizumab)]; Almirall [Psoriasis (Tildrakizumab)]; Amgen [Psoriasis (Etanercept, brodalumab)]; Boehringer Ingelheim [Psoriasis (IL-23 inhibitor)]; Celgene [Psoriasis (Apremilast)]; Dermira [Psoriasis (Certolizumab)]; Janssen [Psoriasis (Ustekinumab)]; Eli Lilly and Company [Psoriasis (Ixekizumab)]; Maruho [Psoriasis (Topical vitamin D)]; Medac [Psoriasis (methotrexate)]; Novartis [Psoriasis (Secukinumab)]; Pfizer [Psoriasis (Tofacitinib)]; UCB [Psoriasis (Certolizumab)]. Other Financial Interest: Scientific Director, Corrona Psoriasis Registry [Psoriasis]."},{"name":"Todd Stultz, DDS, MD","credentials":["Staff, Section of Neuroradiology\n","Imaging Institute\n","Cleveland Clinic"],"disclosure":""},{"name":"C Gail Summers, MD","credentials":["Professor, Departments of Ophthalmology & Visual Neurosciences and Pediatrics\n","University of Minnesota, Minneapolis, MN"],"disclosure":"Grant/Research/Clinical Trial Support: National Eye Institute [Albinism]. Consultant/Advisory Board: National Organization for Albinism and Hypopigmentation [Albinism]."},{"name":"Susan Swetter, MD","credentials":["Professor of Dermatology\n","Director, Pigmented Lesion & Melanoma Program\n","Physician Leader, Cancer Care Program in Cutaneous Oncology\n","Stanford University Medical Center and Cancer Institute/\n","VA Palo Alto Health Care System"],"disclosure":""},{"name":"Patricia Tai, MB, BS, DABR, FRCR, FRCPC","credentials":["Clinical Oncologist\n","Clinical Professor\n","University of Saskatchewan\n","Canada Department of Radiation Oncology\n","Allan Blair Cancer Center"],"disclosure":""},{"name":"Angela Tewari, MBBS, BSc, MRCP, PhD","credentials":["King’s College, London"],"disclosure":""},{"name":"Diane Thiboutot, MD","credentials":["Professor and Vice Chair of Dermatology Research\n","Penn State University College of Medicine"],"disclosure":"Consultant/Advisory Boards: Allergan [Acne (Topical dapsone, tazarotene)]; Dermira [Acne]; Galderma [Acne (Adapalene, adapalene/benzoyl peroxide)]; Novartis [Acne]."},{"name":"Danica Tiodorovic, PhD, MD","credentials":["Associate Professor\n","Clinic of Dermatovenerology, Clinical Center of Nis Medical Faculty\n","University of Nis, Serbia"],"disclosure":""},{"name":"Andres Tirado-Sanchez, MD","credentials":["Professor of Dermatology \n","Anahuac University and Tecnológico de Monterrey"],"disclosure":""},{"name":"Antonella Tosti, MD","credentials":["Professor of Clinical Dermatology\n","Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami"],"disclosure":"Great/Research/Clinical Trial Support: Erchonia [Onychomycosis (Light-emitting diode device)]. Other Financial Interest: Taylor and Francis book royalties [Dermoscopy]; Springer book royalties [Onychomycosis]."},{"name":"James R Treat, MD","credentials":["Associate Professor of Pediatrics and Dermatology\n","Perelman School of Medicine at the University of Pennsylvania; primary appointment at the Children's Hospital of Philadelphia"],"disclosure":"Consultant/Advisory Boards: Proctor and Gamble (Diapers). Speaker's Bureau: Anacor [Atopic dermatitis (Crisaborole)]."},{"name":"Papapit Tuchinda, MD","credentials":["Assistant Professor, Department of Dermatology\n","Siriraj Hospital \n","Mahidol University, Bangkok, Thailand"],"disclosure":""},{"name":"Nathan Uebelhoer, MD","credentials":["Dermatologist\n","Naval Medical Center, San Diego"],"disclosure":""},{"name":"Rashmi Unwala, MD","credentials":["Assistant Professor of Medicine - Department of Dermatology\n","College of Medicine, Mayo Clinic"],"disclosure":""},{"name":"John Varga, MD","credentials":["John and Nancy Hughes Professor of Medicine\n","Northwestern University Feinberg School of Medicine"],"disclosure":""},{"name":"Neelam Vashi, MD","credentials":["Assistant Professor of Dermatology\n","Boston University School of Medicine"],"disclosure":""},{"name":"Allison Vidimos, MD","credentials":["Chairman, Department of Dermatology\n","Vice Chairman, Dermatology and Plastic Surgery Institute\n","Cleveland Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Registry (Vismodegib)]; Regeneron Pharmaceuticals [Squamous cell carcinoma (Anti-PD-1 antibody)]."},{"name":"Miikka Vikkula, MD, PhD","credentials":["Professor of Human Genetics\n","Laboratory of Human Molecular Genetics, de Duve Institute\n","Catholic University of Louvain"],"disclosure":"Grant/Research/Clinical Trial Support (Spouse): Pfizer [Slow-flow vascular anomalies (Rapamycin)]."},{"name":"Ruth Ann Vleugels, MD, MPH","credentials":["Associate Professor in Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Anna Wald, MD, MPH","credentials":["Professor of Medicine, Epidemiology, and Laboratory Medicine\n","University of Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Genocea [Herpes simplex virus (HSV therapeutic vaccine)]; Vical [Herpes simplex virus (HSV therapeutic vaccine)]. Consultant/Advisory Boards: AiCuris [Herpes simplex virus (novel antiviral for HSV)]; GSK [Herpes simplex virus (therapeutic HSV vaccine)]; Merck DSMB [Varicella zoster virus (HSV therapeutic vaccine)]."},{"name":"Karolyn Wanat, MD","credentials":["Clinical Assistant Professor, Department of Dermatology\n","University of Iowa"],"disclosure":""},{"name":"Dana S Ward, MD","credentials":["Associate Professor Emerita of Dermatology\n","University of Missouri"],"disclosure":""},{"name":"Christine B Warren, MD, MS","credentials":["Staff\n","Department of Dermatology, Cleveland Clinic"],"disclosure":""},{"name":"Kalman Watsky, MD","credentials":["Clinical Professor of Dermatology\n","Yale Medical School"],"disclosure":""},{"name":"Alice J Watson, MD, MPH","credentials":["Attending Dermatologist\n","Brigham and Women’s Hospital\n","Instructor in Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Amy C Weintrob, MD","credentials":["Associate Professor of Medicine\n","The George Washington University and Veterans Affairs Medical Center"],"disclosure":""},{"name":"Naissan O Wesley, MD","credentials":["Clinical Professor of Dermatology\n","David Geffen School of Medicine, University of California Los Angeles"],"disclosure":""},{"name":"William L Weston, MD","credentials":["Professor Emeritus of Dermatology\n","University of Colorado Denver School of Medicine"],"disclosure":""},{"name":"David A Wetter, MD","credentials":["Professor of Dermatology\n","Mayo Clinic, Rochester, MN"],"disclosure":""},{"name":"Fredrick M Wigley, MD","credentials":["Professor of Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring [Systemic sclerosis (IVIG)]; Corbus [Systemic sclerosis (JBT-101)]; Boehringer Ingelheim [Interstitial lung disease (Nintedanib)]; Cumberland [Diffuse scleroderma; pulmonary artery hypertension (Ifetroban)]; Sanofi Aventis [Scleroderma lung study III (GSK2330811)]. Patent holder: US6847913B2 - Ambulatory Service Skin Temperature Monitor."},{"name":"Rein Willemze, MD","credentials":["Professor and Chairman, Department of Dermatology\n","Leiden University Medical Center"],"disclosure":""},{"name":"Mary Elizabeth Wilson, MD","credentials":["Clinical Professor of Epidemiology and Biostatistics\n","School of Medicine, University of California, San Francisco\n","Adjunct Professor of Global Health and Population\n","Harvard TH Chan School of Public Health"],"disclosure":""},{"name":"David T Woodley, MD","credentials":["Professor and Chair, Department of Dermatology\n","The Keck School of Medicine, University of Southern California"],"disclosure":""},{"name":"Teresa S Wright, MD, FAAD, FAAP","credentials":["Associate Professor, Dermatology and Pediatrics\n","University of Tennessee Health Science Center\n","Division Chief, Pediatric Dermatology\n","LeBonheur Children's Hospital"],"disclosure":""},{"name":"Eveline Wu, MD","credentials":["Assistant Professor of Pediatrics\n","University of North Carolina at Chapel Hill"],"disclosure":""},{"name":"Peggy A Wu, MD","credentials":["Assistant Professor of Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Kim B Yancey, MD","credentials":["Professor & Chair, Department of Dermatology \n","University of Texas Southwestern Medical Center in Dallas"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [Co-PI on T-32 Award; Participant in a Phase I Multi-Institutional Clinical Trial]. Consultant/Advisory Board: Ashland Chemical Company, Inc. [Personal skin care (Products to help manage mild acne and photo protection)]."},{"name":"James Yiannias, MD","credentials":["Associate Professor\n","Mayo Clinic College of Medicine"],"disclosure":"Other Financial Interest: EmpowHER [Allergic contact dermatitis (Mayo Clinic licenses an online contact allergen avoidance tool)]."},{"name":"Shunsuke Yoshida, MD, MS","credentials":["Resident\n","UNC Plastic & Reconstructive Surgery"],"disclosure":""},{"name":"Gil Yosipovitch, MD","credentials":["Department of Dermatology\n","University of Miami, Miller School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: LEO Foundation [Itch in eczema and psoriasis]; Trevi Therapeutics [Itch (Nalbuphine)]; Menlo Therapeutics [Itch (Neurokinin 1 inhibitor)]; Sun Pharmaceutical Industries [Itch (Crotamiton)]. Consultant/Advisory Boards: Trevi Therapeutics [Itch (Nalbuphine)]; Menlo Therapeutics [Itch (Neurokinin 1 inhibitor)]; Eli Lilly [Itch (Ixekizumab)]; Pfizer [Itch (Tofacitinib, crisaborole)]; Regeneron [Itch (Interleukin 4 and 13)]; Sanofi [Itch (Interleukin 4 and 13)]; Allergen [Itch (OnabotulinumtoxinA)]; OPKO Health [Itch (Neurokinin 1 inhibitor)]; Tioga Pharmaceuticals [Itch (Kappa-opioid receptor)]; Novartis [Itch (H4 antagonist)]; Galderma [Atopic dermatitis and pruritus (Nemolizumab)]; Sienna Pharmaceuticals [Pruritus (Pegcantratinib, SNA-125)]; Vanda Pharmaceuticals [Atopic dermatitis (Kappa opioid receptor antagonist)]."},{"name":"Antony R Young, PhD","credentials":["Professor\n","St John's Institute of Dermatology, Faculty of Life Sciences and Medicine\n","King's College London, London, United Kingdom"],"disclosure":"Grant/Research/Clinical Trial Support: BASF [Sunscreen photoprotection (Sunscreen in development)]. Speaker's Bureau: Pierre Fabre [Sunscreen photoprotection (Over-the-counter sunscreen)]."},{"name":"Andrea Zaenglein, MD","credentials":["Professor of Dermatology and Pediatrics\n","Penn State/Milton S. Hershey Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Ranbaxy Laboratories; Sun Pharmaceuticals Industries [Acne (Isotretinoin)]; Allergan [Acne (Dapsone)]; Dermavant Sciences [Atopic dermatitis (Investigational)]. Speaker's Bureau: Valeant [Atopic dermatitis (Pimecrolimus)]. Consultant/Advisory Boards: Cassiopea [Acne (Investigational)]; Dr Reddy's [Acne (Isotretinoin)]."},{"name":"Iris Zalaudek, MD","credentials":["Associate Professor, Division of Dermatology and Venerology\n","Medical University of Graz"],"disclosure":""},{"name":"Mirjana Ziemer, MD, PhD","credentials":["Senior Physician, Dermatohistopathologist - Department of Dermatology, Venereology, and Allergology\n","University Hospital Leipzig, Leipzig, Germany"],"disclosure":""},{"name":"Matthew J Zirwas, MD","credentials":["Associate Clinical Professor\n","The Ohio State University"],"disclosure":"Grant/Research/Clinical Trial Support: LEO Pharma [Atopic dermatitis (Tralokinumab)]; Janssen Pharmaceuticals [Psoriasis (Guselkumab)]; Foamix Pharmaceuticals [Rosacea, acne (Topical minocycline)]; DS Biopharma [Atopic dermatitis (DS107)]; UCB [Psoriasis (Bimekizumab)]; Incyte [Atopic dermatitis (Ruxolitinib)]. Speaker's Bureau: Regeneron Pharmaceuticals; Sanofi [Atopic dermatitis (Dupilumab); Genentech; Novartis [Chronic urticaria (Omalizumab)]. Consultant/Advisory Boards: Valeant Pharmaceuticals International; Medimetriks Pharmaceuticals; Promius Pharma; Exeltis; Smart Practice; Anacor Pharmaceuticals; Sun Products [Nummular eczema (Cleansers, moisturizers, healing ointments, sunscreen, hydrocortisone butyrate, neomycin-fluocinolone, betamethasone valerate, patch testing materials, crisaborole, laundry detergent, fabric softeners)]; Genentech [Urticarial dermatitis (Omalizumab)]."},{"name":"John J Zone, MD","credentials":["Section Editor — Bullous Disease\n","Professor and Chairman, Department of Dermatology\n","University of Utah"],"disclosure":""},{"name":"Francesco Zulian, MD","credentials":["Chief, Pediatric Rheumatology Unit\n","University of Padua, Italy"],"disclosure":""},{"name":"Bruce Zuraw, MD","credentials":["Professor of Medicine\n","University of California San Diego"],"disclosure":"Consultant/Advisory Boards: Shire [Hereditary angioedema (Icatibant, ecallantide, pdC1INH-nf)]; CSL Behring [Hereditary angioedema (pdC1INH-nf)]; BioCryst [Hereditary angioedema]; Novartis [Allergy]; Genentech [Allergy]. Consultant/Advisory Boards (Spouse): Shire [Hereditary angioedema (Icatibant, ecallantide, pdC1INH-nf)]; CSL Behring [Hereditary angioedema (pdC1INH-nf)]."},{"name":"Fiona Zwald, MD, MRCPI","credentials":["Assistant Professor of Dermatology\n","Department of Dermatology - Emory University"],"disclosure":""},{"name":"Jeffrey Zwerner, MD","credentials":["Assistant Professor of Dermatology\n","Vanderbilt University"],"disclosure":""}]},{"name":"Peer Reviewers","contributors":[{"name":"David M Allen, MD, FAAD","credentials":["Assistant Clinical Professor (Adjunct)\n","University of Utah Department of Dermatology\n","Director\n","Intermountain Skin, Cancer and Esthetics Center"],"disclosure":""},{"name":"Jeremy Bordeaux, MD, MPH","credentials":["Assistant Professor of Dermatology\n","Case Western Reserve University"],"disclosure":""},{"name":"Jerry D Brewer, MD","credentials":["Assistant Professor of Dermatology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Sylvia Brice, MD","credentials":["Associate Professor of Dermatology\n","University of Colorado Denver, School of Medicine"],"disclosure":""},{"name":"Jeffrey Callen, MD, FACP, FAAD","credentials":["Editor-in-Chief — Dermatology\n","Section Editor — Skin and Systemic Disease\n","Professor of Medicine\n","University of Louisville School of Medicine"],"disclosure":"Speaker's Bureau: Biogen [Cutaneous drug reactions in patients with multiple sclerosis]. Consultant/Advisory Boards: Eli Lilly and Company [Pemphigus and hidradenitis (Potential future drugs)]; Amgen [Lupus erythematosus (Potential future drugs)]; Biogen [Cutaneous reaction presentations for neurologists]. Equity Ownership/Stock Ownership: Celgene; Pfizer; 3M; Johnson and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and Gamble; CVS; Walgreens [Various dermatologic conditions (Thalidomide, apremilast, etanercept, adalimumab, tofacitinib)]. Equity Ownership/Stock Ownership (Spouse): Allergen; Celgene; Pfizer; 3M; Johnson and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and Gamble; Amgen; CVS; Walgreens [Various dermatologic conditions (Thalidomide, apremilast, etanercept, adalimumab, tofacitinib)]."},{"name":"Ser Ling Chua, MBBS, FRCP, PhD","credentials":["Consultant Dermatologist\n","Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust"],"disclosure":"Speaker's Bureau: AbbVie [Hidradenitis suppurativa (Adalimumab)]. Consultant/Advisory Boards: Abbvie [Hidradenitis suppurativa (Adalimumab)]."},{"name":"Christina Lee Chung, MD","credentials":["Associate Professor\n","Drexel University"],"disclosure":""},{"name":"Oscar Colegio, MD, PhD","credentials":["Associate Professor of Dermatology, Pathology, and Surgery\n","Yale University School of Medicine"],"disclosure":""},{"name":"Cory A Dunnick, MD","credentials":["Assistant Professor of Dermatology\n","University of Colorado Denver, School of Medicine"],"disclosure":""},{"name":"Jan Peter Dutz, MD","credentials":["Professor - Department of Dermatology and Skin Science\n","University of British Columbia"],"disclosure":""},{"name":"Daniel B Eisen, MD","credentials":["Professor of Clinical Dermatology\n","University of California Davis, Department of Dermatology"],"disclosure":""},{"name":"Anthony F Fransway, MD","credentials":["Associates in Dermatology MD's, LLC\n","Fort Myers, FL"],"disclosure":""},{"name":"Ilona J Frieden, MD","credentials":["Professor of Dermatology and Pediatrics\n","University of California, San Francisco"],"disclosure":"Consultant/Advisory Boards: Pierre Fabre Dermatology [Infantile hemangiomas (Propranolol liquid formulation)]."},{"name":"Anthony Gaspari, MD","credentials":["Chief, Section of Dermatology\n","Lancaster General Hospital"],"disclosure":""},{"name":"Barbara A Gilchrest, MD","credentials":["Professor-in-Residence\n","Department of Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Lynne J Goldberg, MD","credentials":["Professor of Dermatology and Pathology and Laboratory Medicine\n","Boston University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Allergan [Hair growth]; Living Proof."},{"name":"Roderick J Hay, DM","credentials":["Emeritus Professor of Cutaneous Infection\n","King's College London"],"disclosure":""},{"name":"Molly A Hinshaw, MD","credentials":["Clinical Associate Professor of Dermatology\n","UWSMPH, Madison WI\n","Clinical Assistant Professor of Der"],"disclosure":"Patent Holder: Accure Medical, LLC [onychomycosis]. Equity Ownership/Stock Options: Accure Medical, LLC [onychomycosis]."},{"name":"Daniel Hohl, MD","credentials":["Full Professor\n","Lausanne University Hospital"],"disclosure":""},{"name":"J Clark Huff, MD","credentials":["Professor of Dermatology\n","University of Colorado School of Medicine"],"disclosure":""},{"name":"Joseph Jorizzo, MD","credentials":["Professor and Former (Founding) Chair\n","Wake Forest University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Psoriasis]."},{"name":"Brandi M Kenner-Bell, MD, FAAD, FAAP","credentials":["Assistant Professor of Pediatrics and Dermatology\n","Northwestern University's Feinberg School of Medicine\n","Ann & Robert H. Lurie Children's Hospital of Chicago"],"disclosure":""},{"name":"Caroline C Kim, MD","credentials":["Director, Pigmented Lesion Clinic\n","Associate Director, Cutaneous Oncology Program\n","Department of Dermatology\n","Beth Israel Deaconess Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Hoffmann-La Roche [Melanoma (Vemurafenib)]; MetaOptima [Skin imaging (Smartphone attachment for dermoscopy)]. Consultant/Advisory Boards: DAMAE Medical [Skin imaging]."},{"name":"Youn H Kim, MD","credentials":["Professor of Dermatology\n","Stanford University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Esai [CTCL (E7777/denileukin diftitox)], Kyowa Hakko Kirin [CTCL (mogamulizumab)], Merck [CTCL (Pembromulizumab)], Millennium/Takeda [CTCL (brentuximab vedotin)], Seattle Genetics [CTCL (brentuximab vedotin)], Soligenix [CTCL (TOPICAL SGX301)], Tetralogic [CTCL (SHAPE)], Neumedicine [CTCL (Interleukin-12)], Innate [CTCL (IPH4102)], Infinity Pharmaceuticals. Consultant/Advisory Boards: Actelion [CTCL], Celgene [CTCL (Romidepsin)], Eisai [CTCL (E7777/denileukin diftitox)], Galderma [CTCL], Kyowa Hakko Kirin [CTCL (Mogamulizumab)], Millennium/Takeda Pharma [CTCL (Brentuximab Vedotin)], Seattle Genetics [CTCL (Brentuximab Vedotin)], Forty Seven Inc [CTCL], Horizon Pharma [CTCL (Actimmune)], Portola Pharma [CTCL (Cerdulatinib)], miRagen [CTCL (AntimiR-155 MRG-106)], Medivir."},{"name":"Andrew C Krakowski, MD","credentials":["Assistant Clinical Professor\n","University of California, San Diego, and Rady Children's Hospital, San Diego"],"disclosure":""},{"name":"Daniela Kroshinsky, MD","credentials":["Assistant Professor of Dermatology\n","Harvard Medical School"],"disclosure":""},{"name":"Drew Joseph Benedict Kurtzman, MD","credentials":["Assistant Professor of Medicine (Dermatology)\n","Director, Connective Tissue Disease Clinic\n","The University of Arizona"],"disclosure":""},{"name":"Leah Lalor, MD","credentials":["Pediatric Dermatology Fellow\n","University of California, San Francisco School of Medicine"],"disclosure":""},{"name":"Ronald Laxer, MD, FRCPC","credentials":["Professor of Pediatrics\n","University of Toronto"],"disclosure":"Grant/Research/Clinical Trial Support: Scleroderma Society of Ontario [Morphea (Studies)]."},{"name":"Ashfaq A Marghoob, MD","credentials":["Attending Physician\n","Memorial Sloan-Kettering Cancer Center"],"disclosure":""},{"name":"David J Margolis, MD, PhD","credentials":["Associate Professor of Dermatology\n","University of Pennsylvania"],"disclosure":""},{"name":"Catalina Matiz, MD","credentials":["Assistant Professor of Dermatology\n","Division of Pediatric & Adolescent Dermatology, University of California San Diego"],"disclosure":""},{"name":"Beth N McLellan, MD","credentials":["Assistant Professor\n","Albert Einstein College of Medicine"],"disclosure":"Consultant/Advisory Boards: Ferndale Pharma Group [Radiation dermatitis (Polypodium leucotomos extract dietary supplement)]."},{"name":"Jemima Mellerio, BSc, MD, FRCP","credentials":["Consultant Dermatologist & Honorary Senior Lecturer\n","St. John's Institute of Dermatology"],"disclosure":"Grant/Research/Clinical Trial Support: Castle Creek Pharmaceuticals [Epidermolysis bullosa simplex (Diacerein)]. Consultant/Advisory Boards: ProQR Therapeutics [Epidermolysis bullosa (Investigational drug)]; Thornton & Ross [Eczema (Emollients)]."},{"name":"Misha D Miller, MD","credentials":["Assistant Professor\n","Department of Dermatology\n","Department of Obstetrics and Gynecology\n","University of Colorado"],"disclosure":""},{"name":"Eliot Mostow, MD","credentials":["Professor and Chair, Dermatology Section\n","Northeastern Ohio University College of Medicine"],"disclosure":"Consultant/Advisory Boards: Vivacare [Patient information on web and app platforms]. Employment: Elsevier [Dermatology Assistant Editor, practiceupdate.com]."},{"name":"Jenny E Murase, MD","credentials":["Assistant Clinical Professor\n","Department of Dermatology, UCSF"],"disclosure":""},{"name":"Paul T Nghiem, MD, PhD","credentials":["Professor & Head\n","University of Washington Dermatology\n","George F. Odland Chair in Dermatology"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol Myers Squibb [Merkel cell carcinoma (Nivolumab)]; EMD Serono [Merkel cell carcinoma (Avelumab)]. Consultant/Advisory Boards: EMD Serono [Merkel cell carcinoma (Avelumab)]."},{"name":"Cindy Owen, MD","credentials":["Assistant Professor of Medicine\n","University of Louisville"],"disclosure":""},{"name":"Bianca Maria Piraccini, MD, PhD","credentials":["Associate Professor of Dermatology\n","University of Bologna, Italy"],"disclosure":""},{"name":"Maureen B Poh-Fitzpatrick, MD","credentials":["Professor Emerita and Special Lecturer\n","Department of Dermatology, Columbia University College of Ph"],"disclosure":""},{"name":"Ted Rosen, MD","credentials":["Section Editor — Infections and Infestations\n","Professor, Department of Dermatology\n","Baylor College of Medicine"],"disclosure":"Consultant/Advisory Boards: Cipher [Herpes labialis (Acyclovir buccal tablet)]; Medimetriks [Impetigo (Ozenoxacin topical)]."},{"name":"Noah Scheinfeld, MD","credentials":["Assistant Clinical Professor of Dermatology\n","Weill Cornell Medical College"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Hidradenitis suppurativa (Adalimumab)]. Consultant/Advisory Boards: AbbVie [Hidradenitis suppurativa (Adalimumab)]. Speaker’s Bureau: AbbVie [Hidradenitis suppurativa (Adalimumab)]."},{"name":"Robert Sidbury, MD, MPH","credentials":["Professor - Department of Pediatrics\n","University of Washington School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Scioderm [Epidermolysis bullosa (Investigational cream)]; Sanofi/Regeneron [Atopic dermatitis (Investigational biologic)]. Consultant/Advisory Boards: Roche [Acne (Accutane - no longer made)]; Pfizer [Atopic dermatitis (Crisaborole)]."},{"name":"Steven Brett Sloan, MD","credentials":["Associate Professor of Dermatology\n","University of Connecticut"],"disclosure":"Consultant/Advisory Boards: WebMD [slide show advisor]. Employment: Journal of the American Academy of Dermatology."},{"name":"Robert S Stern, MD","credentials":["Section Editor — Nonmelanoma Skin Cancer\n","Professor of Dermatology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Bristol-Myers Squibb [Advance skin cancer (Checkpoint inhibitors)]; Plexxikon [Advance skin cancer (Various drugs)]; Hydra [Advance skin cancer (Various drugs)]. Other Financial Interest: Mylan [Skin reactions (Expert in product liability case concerning phenytoin skin reaction)]; United State Department of Justice [Malpractice defense]."},{"name":"Susan Swetter, MD","credentials":["Professor of Dermatology\n","Director, Pigmented Lesion & Melanoma Program\n","Physician Leader, Cancer Care Program in Cutaneous Oncology\n","Stanford University Medical Center and Cancer Institute/\n","VA Palo Alto Health Care System"],"disclosure":""},{"name":"Brian L Swick, MD","credentials":["Clinical Associate Professor\n","University of Iowa Departments of Dermatology and Pathology\n","Iowa City VAMC"],"disclosure":""},{"name":"Kenneth J Tomecki, MD","credentials":["Department of Dermatology\n","Cleveland Clinic"],"disclosure":""},{"name":"Antonio Torrelo, MD","credentials":["Head, Department of Dermatology\n","Hospital Infantil Universitario Niño Jesus"],"disclosure":""},{"name":"Jashin J Wu, MD, FAAD","credentials":["Director of Dermatology Research\n","Kaiser Permanente Los Angeles Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Psoriasis (Adalimumab)]; Amgen [Psoriasis (Etanercept)]; Eli Lilly [Psoriasis] (ixekizumab); Janssen [Psoriasis (Infliximab, ustekinumab, guselkumab)]; Novartis [Psoriasis (Secukinumab)]; Regeneron [atopic dermatitis (dupilumab)]."},{"name":"Antony R Young, PhD","credentials":["Professor\n","St John's Institute of Dermatology, Faculty of Life Sciences and Medicine\n","King's College London, London, United Kingdom"],"disclosure":"Grant/Research/Clinical Trial Support: BASF [Sunscreen photoprotection (Sunscreen in development)]. Speaker's Bureau: Pierre Fabre [Sunscreen photoprotection (Over-the-counter sunscreen)]."},{"name":"Andrea Zaenglein, MD","credentials":["Professor of Dermatology and Pediatrics\n","Penn State/Milton S. Hershey Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Ranbaxy Laboratories; Sun Pharmaceuticals Industries [Acne (Isotretinoin)]; Allergan [Acne (Dapsone)]; Dermavant Sciences [Atopic dermatitis (Investigational)]. Speaker's Bureau: Valeant [Atopic dermatitis (Pimecrolimus)]. Consultant/Advisory Boards: Cassiopea [Acne (Investigational)]; Dr Reddy's [Acne (Isotretinoin)]."}]}]}